# Chapter 32: Depressive Disorder Due to Another Medical Condition

## Depressive Disorder Due to Another Medical Condition: A Biological and Neurological Perspective

## Introduction

Depressive Disorder Due to Another Medical Condition represents a significant clinical entity at the interface of psychiatry and general medicine (Bains et al., 2021; Steffens et al., 2013). It is defined as a period of depressed mood or markedly diminished interest or pleasure in activities that is judged to be the direct pathophysiological consequence of a general medical condition (Steffens et al., 2013; Dziegielewski, 2014). This diagnosis is not merely an acknowledgment of the emotional distress that accompanies physical illness; it posits a direct biological linkage between the somatic disease process and the emergent mood disorder (Goodwin, 2006; Thom et al., 2019). The relationship between physical and mental health is increasingly understood as bidirectional; physical illness is a potent risk factor for developing severe depressive illness, and conversely, depression is a risk factor for the development and adverse outcome of numerous medical conditions, including cardiovascular disease (Goodwin, 2006; Filipenka, 2021; Steptoe, 2017; Rosenblat et al., 2019).

Historically, the depressive symptoms seen in the medically ill were often conceptualized as a "normal" or understandable psychological reaction to loss, disability, and the stress of chronic illness (Carney & Freedland, 2000; Engel, 1968). While psychological mechanisms undoubtedly play a crucial role (Goodwin, 2006; Lloyd, 2007), a growing body of evidence supports the existence of specific etiological associations where the medical condition directly precipitates depressive symptomatology through shared or interacting neurobiological pathways (Miyoshi, 2001; Thom et al., 2019). This perspective shifts the conceptualization from a purely psychological reaction to a complex neuropsychiatric syndrome rooted in pathophysiology (Dreyer-Oren et al., 2018).

The diagnostic challenge is substantial. The somatic or neurovegetative symptoms of depression—such as fatigue, sleep disturbance, appetite changes, and loss of energy—frequently overlap with the symptoms of the medical illness itself or the side effects of its treatment (Greden, 2003; Chaturvedi & Dhananjayan, 2001; Thom et al., 2019). This symptomatic overlap often leads to both underdiagnosis and misdiagnosis in primary care and hospital settings (Docherty, 1997; Rosenblat et al., 2019; Koenig, 1991). For instance, complaints of fatigue, pain, or insomnia in a patient with a chronic illness might be attributed solely to the physical disease, while the underlying depressive disorder goes unrecognized and untreated (Sharpe & Wilks, 2002; Greden, 2003; Peveler, 2002).

This chapter aims to provide a comprehensive overview of the biological and neurological mechanisms that are believed to underlie Depressive Disorder Due to Another Medical Condition. We will move beyond the purely psychological model to explore how systemic medical illnesses can directly impact brain structure and function to produce a depressive syndrome. By examining the roles of neurotransmitter systems, neuroendocrine pathways, neuroinflammation, genetic vulnerabilities, and neural circuits, we can achieve a more integrated, biopsychosocial understanding of this complex comorbidity (Turabián, 2023). This integrated perspective is essential for accurate diagnosis and the development of targeted, effective treatments that address both the physical and mental health of the patient (Goldberg, 1993; Dilsaver et al., 1988).

## Neurobiological Systems

The development of depressive symptoms in the context of a medical condition is not a random occurrence but is mediated by several interacting biological systems that are disrupted by the underlying disease process. Key pathways implicated include monoaminergic neurotransmitter systems, the neuroendocrine stress-response system (hypothalamic-pituitary-adrenal axis), and the neuro-immune inflammatory network. These systems form a complex, interconnected web where dysfunction in one area can cascade and impact the others, ultimately culminating in the clinical syndrome of depression (van Praag et al., 2004; Claes, 2009).

### Neurotransmitter Systems and Neuropharmacology

The monoamine hypothesis of depression, which posits that a functional deficiency of brain monoaminergic transmitters such as norepinephrine (NE), serotonin (5-HT), and/or dopamine (DA) contributes to depressive symptoms, provides a foundational framework for understanding the neuropharmacology of this disorder (Nayudu Teja et al., 2020; Fiar et al., 2012). Many medical conditions and their treatments can directly or indirectly disrupt these critical neurotransmitter systems (Dilsaver et al., 1988; Miyoshi, 2001). For instance, certain medications used to treat physical illnesses, such as interferon, methyldopa, and steroids, are known to be potential causes of depression, likely through their effects on monoamine metabolism or signaling (Miyoshi, 2001; Dilsaver et al., 1988).

A shared neurochemical link between depression and the physical symptoms that often characterize both depressive episodes and medical illness has been proposed, with serotonin and norepinephrine being central to this connection (Greden, 2003). These neurotransmitters are involved in modulating not only mood but also pain, energy levels, and sleep, which helps explain why antidepressants that target both systems (serotonin-norepinephrine reuptake inhibitors, or SNRIs) may be particularly effective in medically ill patients who present with prominent physical symptoms (Greden, 2003; Holmes et al., 2013). The efficacy of antidepressant drugs, which act by modulating these systems, further supports their role in the pathophysiology of depression, regardless of its primary or secondary nature (Duval et al., 2006; Klerman & Hirschfeld, 1978).

Neurological conditions, in particular, offer a direct window into how brain pathology can alter neurotransmitter function. Post-stroke depression, for example, is strongly associated with lesions in specific brain regions that are rich in monoaminergic pathways (Starkstein & Robinson, 1989; Robinson, 1998). Damage to ascending serotonergic or noradrenergic projections from the brainstem to the frontal cortex can lead to a downstream deficiency in these neurotransmitters, creating a neurochemical environment conducive to depression (Starkstein & Robinson, 1989). Similarly, neurodegenerative diseases like Parkinson's disease, which are defined by the loss of dopaminergic neurons, are frequently accompanied by depression, suggesting a direct link between dopamine deficiency and depressive symptomatology (Bell, 2008; Ahlskog, 2005). The high prevalence of depression in epilepsy also points to a bidirectional relationship, where underlying brain dysfunction and neurotransmitter imbalances may predispose individuals to both seizures and mood disorders (Alsaadi et al., 2013; Schmitz, 2005).

### Neuroendocrine and HPA Axis Dysregulation

The stress of living with a chronic or severe medical illness is a potent activator of the body's primary stress response system, the hypothalamic-pituitary-adrenal (HPA) axis (Chu et al., 2019; Gatchel, 2019). The HPA axis orchestrates the release of glucocorticoids, such as cortisol, to help the body adapt to stressors (Chu et al., 2019). However, prolonged or chronic activation of this system, as is common in many medical conditions, can lead to HPA axis dysfunction, a well-established biological correlate of major depression (Claes, 2009; van Praag et al., 2004).

Chronic stress, whether psychological or physiological, can lead to a state of hypercortisolism, where the normal negative feedback mechanisms that regulate cortisol release become impaired (von Zerssen et al., 1986; Hellhammer & Wade, 1993). This sustained elevation of cortisol has neurotoxic effects, particularly on the hippocampus, a brain region critical for both memory and mood regulation (Đurić & McCarson, 2006; Adams et al., 2018). These neuroendocrine abnormalities are not merely an epiphenomenon but are thought to be a decisive factor in the causation of certain forms of mood disorders (van Praag, 2004; Claes, 2009). For example, in patients with cardiovascular disease, psychological stress triggers neuroendocrine variations that contribute to both the progression of the heart disease and the risk of developing depression (Pignalberi et al., 2002; Esch et al., 2002).

The link between HPA axis dysregulation and depression is further supported by observations in endocrine disorders. Conditions such as Cushing's syndrome (characterized by excess cortisol) and adrenal insufficiency are frequently associated with severe mood disturbances (Pottash, 1981; Williams, 1914; Lauriat & Samson, 2015). Similarly, thyroid and parathyroid dysfunction can present with psychiatric symptoms, including depression and anxiety, highlighting the profound influence of the endocrine system on mental state (Isenberg & Garcia, 2008; Lauriat & Samson, 2015). The administration of exogenous corticosteroids is also a well-known cause of medication-induced mood disorders, providing a pharmacological model of HPA-axis-mediated depression (Miyoshi, 2001; Rosenblat et al., 2019). Thus, the physiological stress imposed by a medical illness can directly drive neuroendocrine changes that create a biological vulnerability to depression (Claes, 2009; Wiegant, 1991).

### Immune System and Neuroinflammation

The inflammatory hypothesis of depression posits that activation of the immune system and subsequent inflammation play a key role in the pathophysiology of mood disorders (Worthen & Beurel, 2022; Hughes et al., 2016). Many chronic medical conditions, such as cardiovascular disease, autoimmune disorders, cancer, and even diabetes, are characterized by a state of chronic, low-grade inflammation (Filipenka, 2021; Goodwin, 2006; Rosenblat et al., 2019). This systemic inflammation can directly impact the brain and induce depressive symptoms.

During an inflammatory response, immune cells release signaling molecules called pro-inflammatory cytokines (e.g., interleukin-1, interleukin-6, tumor necrosis factor-alpha) (Die Trill, 2012). These cytokines can cross the blood-brain barrier or signal to the brain via afferent nerves, triggering a neuroinflammatory response within the central nervous system (Hughes et al., 2016; Worthen & Beurel, 2022). This neuroinflammation can disrupt monoamine neurotransmitter metabolism, impair neuroplasticity, and promote neurotoxic pathways, all of which are implicated in depression (Worthen & Beurel, 2022). The resulting symptom cluster, often termed "sickness behavior," includes fatigue, anhedonia, social withdrawal, and appetite changes—symptoms that significantly overlap with those of major depression (Hughes et al., 2016; Komaroff, 2017).

This mechanism provides a powerful biological explanation for the high rates of depression in diseases with an inflammatory component. For instance, in patients with cancer or those receiving immunotherapy with cytokines like interferon, the development of depression is common and directly linked to the inflammatory load (Die Trill, 2012; Miyoshi, 2001). Similarly, in conditions like rheumatoid arthritis or multiple sclerosis, the underlying autoimmune inflammatory process is thought to contribute directly to the high rates of comorbid depression (Estepa Zabala et al., 2003; Holden & Isaac, 2011). Stress itself, whether from the medical illness or psychosocial factors, can also promote inflammation, creating a vicious cycle where stress, inflammation, and depression mutually reinforce one another (Hughes et al., 2016; van Praag et al., 2004). This interaction between the immune system, the neuroendocrine system, and neurotransmitter pathways highlights how a systemic medical illness can profoundly disturb brain function and lead to a depressive disorder (Worthen & Beurel, 2022; Rosenblat et al., 2019).

## Genetic and Molecular Basis

The development of depression in the context of a medical illness is best understood through a diathesis-stress model, which posits that a pre-existing vulnerability (diathesis) interacts with a precipitating stressor to produce a disorder (Claes, 2009; Parker & Manicavasagar, 2005). In this context, a medical condition serves as a potent biological and psychosocial stressor (Goodwin, 2006). The underlying vulnerability is shaped by a complex interplay of genetic factors, which influence the reactivity of neurobiological systems, and molecular mechanisms that mediate the brain's response to stress and injury.

### Genetic Factors and Heritability

Affective disorders, including major depression and bipolar disorder, are known to have a significant genetic component, with family, twin, and adoption studies demonstrating their heritability (Cadoret & Winokur, 1972; Winokur, 1970; Fox, 1942). This genetic predisposition does not determine the illness but creates a vulnerability (Claes, 2009; Richardson, 2003). For instance, a family history of mood disorders is a known risk factor for developing depression after a stroke (Starkstein & Robinson, 1989) or in the context of other chronic diseases (Cadoret & Winokur, 1972).

Research has begun to identify specific genes that may contribute to this vulnerability. A prominent example is the gene encoding the serotonin transporter (5-HTT), a key protein in the regulation of serotonergic neurotransmission (Claes, 2009). Polymorphisms in this gene have been shown to interact with stressful life events to predict the onset of depression; individuals carrying the "short" allele of the 5-HTT-linked polymorphic region (5-HTTLPR) appear to be more susceptible to developing depression following stress than those with the "long" allele (Claes, 2009). A severe medical illness can be considered a major life stressor that could activate this gene-environment interaction, thereby triggering a depressive episode in a genetically susceptible individual (Claes, 2009; Parker & Manicavasagar, 2005). Genetic factors may also influence the functioning of the HPA axis and the inflammatory response system, further modulating an individual's biological response to the stress of a medical condition (Hellhammer & Wade, 1993; Claes, 2009; Hughes et al., 2016). Ultimately, depression due to a medical condition likely results from a complex polygenetic interaction with environmental variables, where the medical illness acts as a powerful environmental trigger (Huda, 2019; Gold, 2024).

### Cellular and Synaptic Mechanisms

At the molecular and cellular level, the stress and inflammation associated with medical illness can lead to significant changes in brain structure and function, particularly within limbic and prefrontal circuits that regulate mood (Adams et al., 2018). Chronic stress and elevated glucocorticoids, as seen in HPA axis dysregulation, can induce neuronal atrophy, reduce dendritic branching, and inhibit neurogenesis, especially in the hippocampus (Adams et al., 2018; Đurić & McCarson, 2006). These structural changes can impair the function of the hippocampus in regulating both mood and the stress response, contributing to the maintenance of depressive symptoms (Đurić & McCarson, 2008).

Neuroinflammation also has detrimental effects at the cellular level. Pro-inflammatory cytokines can alter neurotransmitter synthesis and release, increase oxidative and nitrosative stress, and shift tryptophan metabolism away from serotonin production and towards the production of neurotoxic metabolites like quinolinic acid (Worthen & Beurel, 2022; Hughes et al., 2016). This creates a neurochemical environment that is less supportive of neuronal health and function.

These pathological processes represent an impairment of structural plasticity and cellular resilience (Duval et al., 2006). Neuroplasticity, the brain's ability to reorganize itself by forming new neural connections, is crucial for adapting to new experiences and for recovery from injury. Factors that promote neuroplasticity, such as brain-derived neurotrophic factor (BDNF), are often reduced in states of depression and chronic stress (Worthen & Beurel, 2022). Conversely, treatments for depression, including antidepressants and exercise, are thought to work in part by restoring neuroplasticity and promoting cellular resilience (Duval et al., 2006; Smith & Blumenthal, 2015). Therefore, the depression seen in medical illness may reflect a state where the cellular and molecular machinery of neuroplasticity is overwhelmed by the combined pathological insults of the disease, its associated stress, and inflammation, leading to a breakdown in the brain's capacity for adaptive emotional regulation (Duval et al., 2006; Gold, 2024).

## Brain Structure and Function

The depressive syndrome that arises from a medical condition is ultimately a manifestation of brain dysfunction (Isenberg & Garcia, 2008; Huda, 2019). The underlying somatic pathology can impact the brain through direct structural damage, as in neurological diseases, or through indirect systemic effects, such as inflammation or metabolic disturbance. These insults disrupt the function of specific brain regions and the neural circuits that connect them, leading to the characteristic cognitive, emotional, and vegetative symptoms of depression (Dreyer-Oren et al., 2018).

### Brain Regions, Neural Circuits, and Functional Connectivity

Evidence from neurological disorders provides the clearest link between structural brain damage and the emergence of depression. Post-stroke depression (PSD) serves as a compelling model, as the location of the brain lesion is a significant predictor of depression risk (House, 1996; Robinson, 1998). Numerous studies have found a strong association between major depression and lesions in the left anterior hemisphere, particularly the left dorsolateral prefrontal cortex and the left basal ganglia (Starkstein & Robinson, 1989; Robinson, 2006). These regions are critical nodes in the cortico-striato-thalamo-cortical loops that are integral to mood regulation, executive function, and motivation (Dreyer-Oren et al., 2018). Damage to these areas or their connecting white matter tracts is thought to disrupt the integrity of these circuits, potentially by interrupting ascending monoaminergic pathways, leading to depressive symptoms (Starkstein & Robinson, 1989). Conversely, lesions in the right hemisphere have been more frequently associated with mania or inappropriate cheerfulness (Starkstein & Robinson, 1989).

Beyond focal lesions, diffuse or systemic processes can also impact these crucial neural circuits. In traumatic brain injury (TBI), diffuse axonal injury can disrupt connectivity across widespread brain networks, contributing to the high rates of post-TBI depression (Jean-Bay, 2000; Gerring, 1986). Similarly, neurodegenerative diseases like Parkinson's disease and Alzheimer's disease involve the progressive deterioration of specific neural systems—dopaminergic pathways in Parkinson's and cortico-limbic circuits in Alzheimer's—that are closely linked to mood regulation, leading to high rates of depression and apathy (Bell, 2008; Novais & SSergio, 2015; Marin, 1991).

The prefrontal-amygdala circuit is another key network implicated in depression due to a medical condition (Lobo et al., 2011). The amygdala is central to processing emotional stimuli, particularly fear and threat, while the prefrontal cortex exerts top-down regulatory control over the amygdala's activity (Anderson, 2007). In depression, this circuit is often dysfunctional, characterized by amygdala hyperactivity and diminished prefrontal control (Anderson, 2007). The chronic stress and inflammation associated with many medical illnesses can exacerbate this imbalance, leading to a state of heightened emotional reactivity and impaired emotional regulation that manifests as anxiety and depression (Lobo et al., 2011; Adams et al., 2018).

### Neuroimaging Findings

Neuroimaging studies in primary depression have revealed a range of structural and functional abnormalities that provide a template for understanding how medical illnesses might impact the brain. While specific imaging biomarkers for depression due to a medical condition are not yet established, findings from related fields are informative.

Structural magnetic resonance imaging (MRI) studies have shown that chronic depression can be associated with volume reduction in key brain areas, most notably the hippocampus and prefrontal cortex (Nasrallah, 2014). This neuronal atrophy is thought to be a consequence of the neurotoxic effects of chronic stress and hypercortisolemia (Adams et al., 2018). In the context of medical illness, pre-existing structural changes, such as subcortical atrophy or white matter hyperintensities (often related to vascular disease), may increase vulnerability to developing depression after a new medical event like a stroke (Starkstein & Robinson, 1989).

Functional neuroimaging techniques, such as functional MRI (fMRI) and positron emission tomography (PET), have identified characteristic patterns of brain activity in depression. These often include hypoactivity in the dorsolateral prefrontal cortex (associated with cognitive symptoms and executive dysfunction) and hyperactivity in the amygdala and subgenual anterior cingulate cortex (associated with negative mood and rumination) (Nasrallah, 2014; Sahakian & Morein-Zamir, 2011). It is plausible that systemic medical conditions could induce similar patterns of functional dysregulation. For example, systemic inflammation is known to alter brain activity in these same limbic and prefrontal regions, providing a direct mechanism by which a medical illness could produce the functional brain signature of depression (Hughes et al., 2016; Worthen & Beurel, 2022). In post-stroke depression, imaging studies have confirmed that metabolic activity is reduced not only at the site of the lesion but also in structurally intact, connected brain regions, demonstrating the network-level effects of a focal injury (Robinson, 1998). These findings support a model where medical conditions, through various pathophysiological mechanisms, disrupt the structure and function of a distributed network of brain regions essential for healthy mood regulation (Dreyer-Oren et al., 2018).

## Developmental Neurobiology

The emergence of Depressive Disorder Due to Another Medical Condition is profoundly influenced by developmental factors and an individual's life history (Tiganov, 2013). The brain's response to the physiological and psychological stress of a medical illness is not uniform across the lifespan but is shaped by critical periods of development, the accumulated impact of prior life experiences, and age-related changes in neurobiology (van der Kolk, 1998; Martins-Monteverde et al., 2017).

### Vulnerability Across the Lifespan

Early life experiences, particularly exposure to trauma, abuse, or chronic psychosocial adversity, can have lasting effects on the development of stress-response systems, creating a long-term vulnerability to depression (van der Kolk, 1998; Claes, 2009; Martins-Monteverde et al., 2017). Such experiences can program the HPA axis to be hyper-responsive to stressors later in life and may induce epigenetic changes that alter the expression of genes involved in stress regulation and neuroplasticity (Claes, 2009). An individual with this sensitized biological substrate may be more likely to develop a depressive disorder when confronted with the significant stress of a medical diagnosis in adulthood or later life (Parker & Manicavasagar, 2005; Martins-Monteverde et al., 2017).

The timing of the medical illness itself is also critical. In children and adolescents, whose brains are still undergoing significant development, a chronic illness can disrupt normal psychosocial maturation and neurodevelopmental processes (Finch, 1975; Pao & Bosk, 2010). The stress of the illness can interfere with the development of secure attachments, peer relationships, and academic achievement, all of which are protective factors for mental health (Kerfoot, 2005). Furthermore, the biological impact of the illness (e.g., inflammation, HPA axis activation) on a developing brain may have more profound and lasting consequences than in an adult brain (Tiganov, 2013).

In late life, depression is particularly common and frequently co-occurs with chronic medical illnesses, severe disability, and cognitive decline (Friedhoff, 1992; Kales & Valenstein, 2002; Sekhon et al., 2019). The aging process itself involves neurobiological changes, such as a decline in certain neurotransmitter systems and increased vulnerability to vascular and inflammatory insults, that may lower the threshold for developing depression (Ritchie, 2014; Gonda et al., 2009). Late-onset depression—the first episode occurring after age 60—is often associated with underlying neurological or vascular brain changes ("vascular depression"), suggesting that age-related neuropathology is a key contributor (Ritchie, 2014; Alexopoulos, 2014). The accumulation of medical comorbidities, functional limitations, social losses (e.g., bereavement, isolation), and financial stressors in old age creates a powerful confluence of factors that can precipitate depression in an aging brain (Friedhoff, 1992; Gonda et al., 2009; Capurso et al., 2007). Therefore, the clinical presentation and underlying biology of depression due to a medical condition can vary significantly depending on the developmental stage at which the illness occurs (Tiganov, 2013).

## Treatment Mechanisms

Understanding the biological underpinnings of depression secondary to a medical condition provides a rationale for various treatment strategies, which aim to correct the identified neurobiological dysfunctions. The goal of treatment is not only to alleviate depressive symptoms but also to promote neuroplasticity, enhance cellular resilience, and potentially improve the outcome of the underlying medical illness itself (Duval et al., 2006; Robinson, 1998).

### Pharmacological and Somatic Interventions

Pharmacotherapy remains a cornerstone of treatment, targeting the neurotransmitter systems implicated in depression (Klerman & Hirschfeld, 1978; Dilsaver et al., 1988). Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are often first-line agents, chosen for their efficacy and generally favorable side-effect profiles in medically complex patients (Rosenblat et al., 2019; Greden, 2003). By increasing the synaptic availability of serotonin and/or norepinephrine, these medications help to restore normative function in the monoaminergic circuits disrupted by the medical illness and its associated stress (Duval et al., 2006). The analgesic properties of some antidepressants, particularly SNRIs and tricyclic antidepressants (TCAs), make them especially useful in patients where chronic pain is a significant component of both the medical condition and the depressive syndrome, reflecting the shared neurochemical pathways for mood and pain (Holmes et al., 2013; Tütüncü, 2011; Greden, 2003).

In more severe or treatment-resistant cases, particularly those with psychotic features or high suicide risk, electroconvulsive therapy (ECT) is a highly effective option (Dubovsky & Thomas, 1992; Fink, 2010). ECT is thought to work by inducing widespread neurochemical changes, enhancing neurotransmission, and promoting neuroplasticity and neurogenesis (Fink, 2010). Its rapid onset of action makes it particularly valuable in medically frail patients who may not be able to tolerate the side effects or wait for the delayed therapeutic effect of antidepressant medications (Koenig, 1991).

### Neuroplasticity, Compensatory Mechanisms, and Psychosocial Approaches

Beyond direct neurochemical modulation, effective treatments for depression are believed to foster brain plasticity and resilience (Duval et al., 2006). Chronic stress and inflammation associated with medical illness can be neurotoxic, leading to neuronal atrophy and impaired circuit function (Adams et al., 2018; Worthen & Beurel, 2022). Antidepressant treatments, along with psychosocial interventions, may counteract these effects by increasing levels of neurotrophic factors like BDNF, stimulating neurogenesis, and restoring synaptic connectivity (Duval et al., 2006).

Psychological treatments, such as cognitive-behavioral therapy (CBT) and interpersonal therapy (IPT), are also effective and play a critical role in management (Green, 1996; Sharpe & Wessely, 2020). These therapies help patients develop adaptive coping strategies, challenge negative cognitive patterns, and address the interpersonal and role-related difficulties that accompany chronic illness (Green, 1996). From a biological perspective, these interventions may work by strengthening top-down prefrontal cortical control over limbic structures like the amygdala, thereby improving emotional regulation (Sahakian & Morein-Zamir, 2011). By reducing the psychological stress load, psychotherapy can also lead to a downstream normalization of HPA axis activity and a reduction in inflammatory processes (Hughes et al., 2016).

Furthermore, non-pharmacological interventions like physical exercise have demonstrated efficacy in treating depression (Smith & Blumenthal, 2015; Carek et al., 2011). Exercise is known to increase endorphins, modulate monoamine systems, reduce inflammation, and enhance BDNF levels, directly targeting many of the pathophysiological mechanisms discussed (Chaouloff et al., 2013; Smith & Blumenthal, 2015). In the context of medical illness, a graded exercise program can not only improve depressive symptoms but also enhance physical function and overall quality of life, highlighting the value of an integrated, multimodal treatment approach (Robinson, 1998; Rosenblat et al., 2019).

## Future Directions

The study of Depressive Disorder Due to Another Medical Condition is a rapidly evolving field, yet many questions remain unanswered. The significant clinical and etiological heterogeneity of this condition underscores the need for more nuanced and sophisticated research to move the field forward (Patten, 2015; Rosenblat et al., 2019).

A primary challenge is the development of reliable biomarkers to aid in diagnosis and treatment selection (Anisman & Hayley, 2012). Currently, the diagnosis relies on clinical judgment to attribute depressive symptoms to a medical condition, a process complicated by symptomatic overlap (Thom et al., 2019). Future research should focus on identifying specific biological signatures—such as patterns of inflammatory markers, neuroendocrine profiles, or neuroimaging findings—that can differentiate depression secondary to a medical condition from primary major depression, adjustment disorders, or the normal distress of being ill (O'Keeffe & Ranjith, 2007). For example, are there specific cytokine profiles in patients with cardiovascular disease that predict the development of a depressive syndrome versus a non-depressed response to the illness (Hughes et al., 2016)? Such biomarkers could lead to more precise diagnoses and facilitate early, targeted interventions.

Further investigation into biological subtypes is crucial. It is unlikely that depression resulting from a stroke, an autoimmune disease, or a metabolic disorder share the exact same pathophysiology (Goodwin, 2006). Research is needed to delineate the specific mechanisms at play in different medical contexts. For instance, studies could explore how the direct neural circuit disruption in post-stroke depression differs from the primarily inflammatory and neuroendocrine pathways in depression associated with rheumatoid arthritis (Robinson, 2006; Estepa Zabala et al., 2003). This line of inquiry could pave the way for more personalized medicine, where treatment is tailored to the specific biological subtype of depression.

The interaction between genetic vulnerability and specific medical stressors also warrants deeper exploration (Claes, 2009). While the role of genes like the serotonin transporter in moderating the effects of psychosocial stress is established, how these and other genetic variants interact with the specific biological insults of different diseases is poorly understood. Future genomic studies could identify genetic risk factors that predispose individuals to depression in the context of specific medical conditions, allowing for proactive screening and preventive strategies in high-risk populations.

Finally, there is a need for more robust clinical trials of both pharmacological and non-pharmacological interventions specifically in medically ill populations (Rosenblat et al., 2019). Many treatment guidelines are extrapolated from studies of physically healthy individuals, which may not be appropriate given the unique biological and psychosocial context of medical comorbidity (Thom et al., 2019). Future trials should not only assess the efficacy of treatments on depressive symptoms but also on functional outcomes, quality of life, and the course of the underlying medical illness itself (Robinson, 1998). Investigating novel therapeutic approaches that target mechanisms like neuroinflammation or HPA axis dysfunction directly could provide new hope for this complex and challenging patient population.

## Conclusion

Depressive Disorder Due to Another Medical Condition is a complex neuropsychiatric syndrome that extends far beyond a simple psychological reaction to physical illness (Goodwin, 2006; Thom et al., 2019). As this chapter has detailed, a confluence of biological and neurological mechanisms directly links somatic pathology to the onset of a depressive episode. The physiological and psychological stress of chronic or acute medical illness acts upon a substrate of individual vulnerability, shaped by genetic and developmental factors, to disrupt the brain's homeostatic systems (Claes, 2009; van Praag et al., 2004; Gold, 2024).

The key pathways implicated in this process are intricately interconnected. Chronic activation of the HPA axis leads to neuroendocrine dysregulation and potential neurotoxic effects, particularly in the hippocampus (Chu et al., 2019; Đurić & McCarson, 2008). Systemic inflammation, a hallmark of many medical diseases, triggers a neuroinflammatory cascade that alters monoamine metabolism and impairs neuroplasticity (Worthen & Beurel, 2022; Hughes et al., 2016). Direct insults to the brain, as seen in stroke or neurodegenerative diseases, cause structural and functional damage to critical mood-regulating circuits, such as the prefrontal cortex and basal ganglia (Starkstein & Robinson, 1989; Robinson, 2006).

This biological perspective underscores that the depressive symptoms experienced by medically ill patients are not a sign of personal weakness but a manifestation of brain dysfunction (Filipenka, 2021; Huda, 2019). Recognizing this is crucial for destigmatizing the condition and promoting effective treatment. The diagnostic challenge posed by overlapping somatic symptoms requires clinicians to look beyond physical complaints and assess for the core psychological and cognitive features of depression (Greden, 2003; Kapfhammer, 2006).

An integrated, biopsychosocial approach is essential for both diagnosis and management (Turabián, 2023; Green, 1996). Treatment must be multimodal, combining evidence-based pharmacotherapy aimed at correcting neurochemical imbalances with psychotherapeutic interventions that address maladaptive cognitions, enhance coping skills, and provide psychosocial support (Rosenblat et al., 2019; Sharpe & Wessely, 2020). By understanding and targeting the underlying biological mechanisms, clinicians can not only alleviate the profound suffering of depression but also potentially improve functional recovery, quality of life, and even the prognosis of the co-occurring medical condition (Robinson, 1998; Thom et al., 2019). The continued exploration of this intricate mind-body interface remains one of the most critical frontiers in modern medicine.

## References

1. Abe, Y., & Germai, A. (2012). Insomnia and Its Correlates: Current Concepts, Epidemiology, Pathophysiology and Future Remarks. InTech eBooks. https://doi.org/10.5772/36102
2. Abendroth, B., Schulz, S., Dost, A., & Abendroth, Κ. (2020). Osteologische Aspekte beim Chronic Fatigue Syndrom (CFS) am Beispiel eines 17-jährigen Jungen. Osteologie/Osteology. https://doi.org/10.1055/s-0039-3402877
3. Adams, T. G., Kelmendi, B., Brake, C. A., Gruner, P., Badour, C. L., & Pittenger, C. (2018). The Role of Stress in the Pathogenesis and Maintenance of Obsessive-Compulsive Disorder. Chronic Stress. https://doi.org/10.1177/2470547018758043
4. Addington, D. (2006). Депрессия при шизофрении. Социальная и клиническая психиатрия.
5. Adler, G. (2006). Diagnostik der Demenz. Notfall & Hausarztmedizin (Notfallmedizin). https://doi.org/10.1055/s-2006-959110
6. Adán, J. C. M., Herrer, M. G., Cuadrado, P. D. P., & García, M. D. G. (2009). El paciente que padece un trastorno depresivo en el trabajo. Medicina y Seguridad del Trabajo. https://doi.org/10.4321/s0465-546x2009000100004
7. Agarwal, V., Sitholey, P., & Srivastava, C. (2019). Clinical practice guidelines for the management of dissociative disorders in children and adolescents. Indian Journal of Psychiatry. https://doi.org/10.4103/psychiatry.indianjpsychiatry_493_18
8. Agudelo, D., Buela‐Casal, G., & Spielberger, C. D. (2007). Ansiedad y depresión: el problema de la diferenciación a través de los síntomas. Salud Mental.
9. Agudelo, D., Spielberger, C. D., & Buela‐Casal, G. (2007). La depresión: ¿un trastorno dimensional o categorial?. Salud Mental.
10. Ahlskog, J. E. (2005). Depression. https://doi.org/10.1093/oso/9780195171938.003.0022
11. Al-Dallee, N. M. Y. (2017). Salivary biomarkers of stress in psychological patients on fluoxetine therapy.
12. Alanbagi, A. A., & Al-Zamily, R. H. (2019). The depression among cancer patients during chemotherapy and its relation to demographic and social data. International Journal of Research in Pharmaceutical Sciences.
13. Alayarian, A. (2018). My experience of clinical work with refugees and asylum seekers. Routledge eBooks. https://doi.org/10.4324/9780429479595-9
14. Ali, A. M. (2018). So, Antidepressant Drugs have Serious Adverse Effects, but what are the Alternatives?. Novel Approaches in Drug Designing & Development. https://doi.org/10.19080/napdd.2018.04.555636
15. Aligeti, S., Baig, M. R., & Barrera, F. F. (2015). Terminal delirium misdiagnosed as major psychiatric disorder: Palliative care in a psychiatric inpatient unit. Palliative & Supportive Care. https://doi.org/10.1017/s147895151500098x
16. Alsaadi, T., Zamel, K., Sameer, A., Fathalla, W., & Koudier, I. (2013). Depressive disorders in patients with epilepsy: Why should neurologists care?. Health. https://doi.org/10.4236/health.2013.56a1003
17. Altamura, A., Cattaneo, E., Pozzoli, S., Bassetti, R., & Sacco, L. (2006). Inquadramento diagnostico e gestione farmacologica della depressione senile Assessment and pharmacological management of elderly depression.
18. Anderson, A. K. (2007). Feeling emotional: the amygdala links emotional perception and experience. Social Cognitive and Affective Neuroscience. https://doi.org/10.1093/scan/nsm022
19. Anderson, R. C. (2003). Body Dysmorphic Disorder. Plastic Surgical Nursing. https://doi.org/10.1097/00006527-200323030-00007
20. Anderson, T., Heitger, M., & Macleod, A. D. (2006). Concussion and mild head injury. Practical Neurology. https://doi.org/10.1136/jnnp.2006.106583
21. Anisman, H., & Hayley, S. (2012). Illness comorbidity as a biomarker?. Journal of Psychiatry and Neuroscience. https://doi.org/10.1503/jpn.120092
22. Argyriou, A. A., Anastopoulou, G. G., & Bruna, J. (2018). Inconclusive evidence to support the use of minimally-invasive radiofrequency denervation against chronic low back pain. Annals of Translational Medicine. https://doi.org/10.21037/atm.2018.01.23
23. Ariff, K. M., & Hassan, Z. A. (2006). Insomnia: Case Studies In Family Practice.. DOAJ (DOAJ: Directory of Open Access Journals).
24. As, T. (2013). [Age-related aspects of depressive states].. PubMed.
25. Asakawa, A., & Inui, A. (2013). 2. Psychosomatic Aspects-Role of Stress and Hormone in Functional Gastrointestinal Disorder. Nihon Naika Gakkai Zasshi. https://doi.org/10.2169/naika.102.11
26. Atzeni, F., Altomonte, L., Leardini, G., Marsico, A., Gorla, R., Casale, R., Cassisi, G., Stisi, S., Salaffi, F., Marinangeli, F., Giamberardino, M., Franco, M. D., Biasi, G., Arioli, G., Alciati, A., Ceccherelli, F., Bazzichi, L., Carignola, R., Cazzola, M., ... Sarzi‐Puttini, P. (2011). Fibromyalgia syndrome: preventive, social and economic aspects. Reumatismo. https://doi.org/10.4081/reumatismo.2008.1s.70
27. Autor, R. N. C. M., Principal, C. A. V. S. T., Adjunta, G. C. L. T., & Externa, S. S. R. T. (2017). Interacción del estrés, empatía, satisfacción y fatiga en médicos de Urgencias.
28. Autor, S. (2002). CÁPSULAS PARA LA VIDA.- ANSIEDAD. Gaceta UNAM (2000-2009).
29. Avari, J., Yuen, G. S., AbdelMalak, B., Mahgoub, N., Kalayam, B., & Alexopoulos, G. S. (2014). Assessment and Management of Late-Life Depression. Psychiatric Annals. https://doi.org/10.3928/00485713-20140306-04
30. B.R, R., & N.K.C, E. (2019). A review on pain and its signals modulation by body. IP International Journal of Comprehensive and Advanced Pharmacology. https://doi.org/10.18231/j.ijcaap.2019.018
31. Ba, V. D. K. (1998). [Psychology and psychobiology of childhood trauma].. PubMed.
32. Bains, N., Abdijadid, S., & Miller, J. (2021). Major Depressive Disorder (Nursing).
33. Balhara, Y. P. S., Mohan, I., Sagar, R., & Chawla, J. (2006). Chronic mania: An unexpectidly long episode?. Indian Journal of Medical Sciences. https://doi.org/10.4103/0019-5359.25681
34. Barkin, R. L. (2007). Zolpidem Extended-Release: A Single Insomnia Treatment Option for Sleep Induction and Sleep Maintenance Symptoms. American Journal of Therapeutics. https://doi.org/10.1097/mjt.0b013e31804c7292
35. Barnes, T. R. E., & Paton, C. (2011). Do antidepressants improve negative symptoms in schizophrenia?. BMJ. https://doi.org/10.1136/bmj.d3371
36. Bass, C., & Wade, D. T. (2018). Malingering and factitious disorder. Practical Neurology. https://doi.org/10.1136/practneurol-2018-001950
37. Bassil, N., Ghandour, A., & Grossberg, G. T. (2011). How Anxiety Presents Differently in Older Adults: Age-Related Changes, Medical Comorbidities Alter Presentation and Treatment. Current psychiatry.
38. Beaudreau, S. A., & Gould, C. E. (2015). Definition of Mental Disorder. The Encyclopedia of Adulthood and Aging. https://doi.org/10.1002/9781118521373.wbeaa190
39. Beghi, E., Carpio, A., Forsgren, L., Hesdorffer, D. C., Malmgren, K., Sander, J. W., Tomson, T., & Hauser, W. A. (2009). Recommendation for a definition of acute symptomatic seizure. Epilepsia. https://doi.org/10.1111/j.1528-1167.2009.02285.x
40. Bell, B. (2008). Depression and Parkinson’s Disease. touchREVIEWS in Neurology. https://doi.org/10.17925/usn.2008.04.01.67
41. Benatmane, M., Benhabiles, S., Machane, R., Hammal, K., & Sinaceur, S. (2014). La dépression peut mimer n’importe quelle maladie : à propos d’un cas clinique. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2014.09.241
42. Bersani, F. S., Mellon, S. H., Reus, V. I., & Wolkowitz, O. M. (2019). Accelerated aging in serious mental disorders. Current Opinion in Psychiatry. https://doi.org/10.1097/yco.0000000000000525
43. Bertodo, T. D. S., Gross, M. S., & Maldaner, E. B. (2018). TRANSTORNOS BIPOLAR E DEPRESSIVO: UMA REVISÃO DOS ASPECTOS CONCEITUAIS.
44. Bhatia, N., Maiti, P., Choudhary, A., Tuli, A., Masih, D., Masih, M., Khan, U., Ara, T., & Jaggi, A. S. (2011). None. International Journal of Pharmaceutical Sciences and Research. https://doi.org/10.13040/ijpsr.0975-8232.2(5).1147-55
45. Bitnun, A., & Richardson, S. E. (2015). Childhood Encephalitis in Canada in 2015. Canadian Journal of Infectious Diseases and Medical Microbiology. https://doi.org/10.1155/2015/947602
46. Blanc, F., & Verny, M. (2017). Prodromal stage of disease (dementia) with Lewy bodies, how to diagnose in practice?. Gériatrie et Psychologie Neuropsychiatrie du Viellissement. https://doi.org/10.1684/pnv.2017.0675
47. Blanco, K. E. J., Velásquez, J. M. A., Balthazar, V., Alejandra, N., Espinosa, Z., & Maya, G. C. (2011). Talla baja de causas no endocrinas Short stature due to non-endocrine causes.
48. Blaney, P. H. (2015). Medical Model of Mental Disorders. The Encyclopedia of Clinical Psychology. https://doi.org/10.1002/9781118625392.wbecp382
49. Blumenfeld, R. S. (2020). Neuropsychiatric Disorders. The Wiley Encyclopedia of Personality and Individual Differences. https://doi.org/10.1002/9781118970843.ch288
50. Blumenfeld, R. S. (2020). Neuropsychiatric Disorders. The Wiley Encyclopedia of Personality and Individual Differences. https://doi.org/10.1002/9781119547181.ch288
51. Bogousslavsky, J., Staub, F., & Pr, J. (2000). Les syndromes de fatigue d'origine cérébrale. Schweizer Archiv für Neurologie und Psychiatrie. https://doi.org/10.4414/sanp.2000.01189
52. Bonevski, D., & Naumovska, A. (2018). Trauma and Anxiety Disorders throughout lifespan: Fear and anxiety from normality to disorder.. PubMed.
53. Bonnet, M. H., & Arand, D. L. (2013). Insomnia. https://doi.org/10.3920/9789086867639_003
54. Boora, S. (2013). Influence of Age and Work Experience on Depression among Working Women in Delhi/NCR. International journal of education and management studies.
55. Bravo, M. D. L. (2011). Ansiedad y depresión en la vejez.
56. Brech, G. C., Andrusaitis, S. F., Vitale, G. F., & Greve, J. M. D. (2012). Correlation of disability and pain with postural balance among women with chronic low back pain. Clinics. https://doi.org/10.6061/clinics/2012(08)17
57. Brinkmann, B. H. (2021). Mental Disorder Issues in People.
58. Brody, D. L. (2014). Dizziness. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199383863.003.0014
59. Brody, D. L. (2014). Personality Change. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199383863.003.0012
60. Bronstein, A. M., & Lempert, T. (2013). Symptoms and Syndromes in the Patient with Dizziness or Unsteadiness. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199608997.003.0011
61. Brown, C., & Mehler, P. S. (2013). Medical Complications of Self-Induced Vomiting. Eating Disorders. https://doi.org/10.1080/10640266.2013.797317
62. Buckley, P., & Foster, A. (2014). Schizophrenia. https://doi.org/10.1007/978-3-7091-0715-7_4
63. Buist‐Bouwman, M. A. (2007). Functional limitations associated with mental disorders : inescapable fact or avoidable reality?.
64. Burn, D. J. (2006). Movement disorders: a brief practical approach to diagnosis and management. The Journal of the Royal College of Physicians of Edinburgh. https://doi.org/10.1177/1478271520063604014
65. Buselli, R., Bozzi, S., Baldanzi, S., & Cristaudo, A. (2012). Le patologie da stress lavoro-correlato: peculiarità della diagnosi clinico-eziologica. Pratica Medica & Aspetti Legali. https://doi.org/10.7175/pmeal.v6i2.293
66. Cabaniss, D. L., Moga, D. E., & Hyun, A. (2013). The psychodynamic treatment of mood disorders. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781139175869.022
67. Cadoret, R. J., & Winokur, G. (1972). Genetic Principles in the Classification of Affective Illnesses. International Journal of Mental Health. https://doi.org/10.1080/00207411.1972.11448572
68. Canbulat, N., & Sonay, A. (2012). Pain Management and Nursing Approaches in Pediatric Oncology. InTech eBooks. https://doi.org/10.5772/32053
69. Caplan, R., Bursch, B., & Leipzig, A. (2012). Somatization. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199843824.003.0079
70. Capurso, A., Capurso, C., Solfrizzi, V., Colacicco, A. M., D’Introno, A., & Panza, F. (2007). [Depression in old age: a diagnostic and therapeutic challenge].. Recenti Progressi in Medicina.
71. Caraiane, A., Szalontay, A. S., Macovei, L. A., Romila, A., Indrei, L. L., Decusară, M., & Tarc, T. (2018). Oral-Facial Manifestations Caused by the Use of Psychotropic Medication in Psychiatric Patients. Revista de Chimie. https://doi.org/10.37358/rc.18.6.6374
72. Carek, P. J., Laibstain, S. E., & Carek, S. M. (2011). Exercise for the Treatment of Depression and Anxiety. The International Journal of Psychiatry in Medicine. https://doi.org/10.2190/pm.41.1.c
73. Carney, R. M., & Freedland, K. E. (2000). Depression and Medical Illness. https://doi.org/10.1093/oso/9780195083316.003.0009
74. Carota, A., Diéguez, S., & Bogousslavsky, J. (2005). Psychopathology of stroke. Gériatrie et Psychologie Neuropsychiatrie du Viellissement.
75. CASEY, P., & Bailey, S. (2011). Adjustment disorders: the state of the art. World Psychiatry. https://doi.org/10.1002/j.2051-5545.2011.tb00003.x
76. Castillo-Villanueva, E., Coy, P. E. C., Shejet, F. O., Durán, E. T., & Cabrera, D. M. (2010). Evaluación de funciones cognitivas: atención y memoria en pacientes con trastorno de pánico. Salud Mental.
77. Catalina, M., Ugarte, L. D., & Moreno, C. M. (2009). A case report. Factitious disorder with psychological symptoms. Is confrontation useful.
78. Chaouloff, F., Dubreucq, S., Matias, I., & Marsicano, G. (2013). Physical activity feel-good effect:The role of endocannabinoids. Routledge eBooks. https://doi.org/10.4324/9780203132678-12
79. Charles, A. (2012). Migraine is not primarily a vascular disorder. Cephalalgia. https://doi.org/10.1177/0333102412441717
80. Charlton, S. R. (2020). Psychology and Black History Month in the United States. Eye on Psi Chi Magazine. https://doi.org/10.24839/2164-9812.eye24.4.18
81. Chaturvedi, S. K., & Dhananjayan, V. (2001). Depression in medical disorders.. PubMed.
82. Chaudhry, S. (2020). Depression and its Dilemma. IP Journal of Surgery and Allied Sciences. https://doi.org/10.18231/j.jsas.2020.013
83. Chew‐Graham, C., Heyland, S., Kingstone, T., Shepherd, T., Buszewicz, M., Burroughs, H., & Sumathipala, A. (2017). Medically unexplained symptoms: continuing challenges for primary care. British Journal of General Practice. https://doi.org/10.3399/bjgp17x689473
84. Chu, B., Marwaha, K., Sanvictores, T., & Ayers, D. (2019). Physiology, Stress Reaction. StatPearls.
85. Claes, S. (2009). [Stress and depression: clinical, neurobiological and genetical perspectives].. PubMed.
86. Clark, J. D., Rager, D. R., & Calpin, J. P. (1997). Animal well-being. II. Stress and distress.. PubMed.
87. Clark, J. D., Rager, D. R., & Calpin, J. P. (1997). Animal well-being. III. An overview of assessment.. PubMed.
88. Cogan, E. (2002). [Chronic fatigue syndrome: the point of view of the internist].. PubMed.
89. Cohen, M. (2001). Happiness and humour. A medical perspective.. PubMed.
90. Copeland‐Linder, N., Onigu-Otite, E., Serico, J. M., Jamora, M., & Belcher, H. M. E. (2017). Neurobiology of Child Maltreatment and Psychological Trauma. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199937837.003.0181
91. Coronado, L. M. Q., Florez, D. A. C., & Tarazona, M. C. L. (2017). Prevalencia depresión en estudiantes universitarios Bucaramanga 2017.
92. Couto, F. S. D., & Mendonça, A. D. (2010). Sintomas psiquiátricos e comportamentais da demência. Revista Portuguesa de Clínica Geral. https://doi.org/10.32385/rpmgf.v26i1.10713
93. Craig, T., & Kakumanu, S. (2002). Chronic fatigue syndrome: evaluation and treatment.. PubMed.
94. Cruz, M. C. D., Cruz, L. C. D., Cruz, M. C. C. D., & Camargo, R. P. D. (2017). Cefaleia do tipo tensional: revisão de literatura. ARCHIVES OF HEALTH INVESTIGATION. https://doi.org/10.21270/archi.v6i2.1778
95. Cruz, V. E. R., Palacios, L. P. T., Adriano, M. P. C., Lozada, E. M. V., Quingatuña, D. E. E., Reyes, E. P. B., Sailema, P. I. Y., Inca, J. I. S., & Ruiz, G. B. F. (2020). Avances en el manejo del delirium en los pacientes geriátricos. AVFT – Archivos Venezolanos de Farmacología y Terapéutica. https://doi.org/10.5281/zenodo.4058882
96. Cuijpers, P. (2010). Postpartum Depression. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0697
97. Cupelli, R. H., Weise, A., Barbero, M., & Kool, J. (2017). Interim report: Development and evaluation of a three-week inpatient fatigue management education protocol for persons with MS-related fatigue.
98. Cvijanović, M., Simić, S., Banic-Horvat, S., Jovin, Z., Slankamenac, P., & Ilin, M. (2011). Contemporary treatment neuropathic pain. Medicinski pregled. https://doi.org/10.2298/mpns1110443c
99. Călin, A. M., Debita, M., Ciurcanu, O. E., Scutariu, M. M., & Szalontay, A. S. (2017). Xerostomia and Hyposalivation in Patients with Physical and Psychological Disabilities. Revista de Chimie. https://doi.org/10.37358/rc.17.10.5902
100. Dadkhah, B., Valizadeh, S., Mohammadi, E., & Hassankhani, H. (2013). Psychosocial adjustment to lower-limb amputation: A review article.
101. Daley, D. C., & Douaihy, A. (2019). Substance-Related Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780190926632.003.0002
102. Dalvi, A., Lyons, K. E., & Pahwa, R. (2006). Secondary Dystonia. CRC Press eBooks. https://doi.org/10.3109/9781420019988-19
103. Dalvi, A., Lyons, K. E., & Pahwa, R. (2012). Secondary dystonia. CRC Press eBooks. https://doi.org/10.3109/9781841848525-20
104. Davidhizar, R., & Cramer, C. (2001). The employee who seeks to benefit from being ill.. PubMed.
105. Davoine, G.-A., Godinat, G., Petite, D., & Saurer, A. (2013). [Medically unexplained persistent pain syndrome: psychoanalytic approach].. PubMed.
106. Deantri, F., & Sawitri, A. A. S. (2020). PROPORSI STRES DAN GEJALA PSIKOSOMATIK PADA SISWA KELAS XII SEKOLAH MENENGAH ATAS DI KOTA DENPASAR. JURNAL BIOS LOGOS. https://doi.org/10.35799/jbl.10.1.2020.27465
107. Dedeli, Ö., & Akyol, A. D. (2005). Yoğun Bakım Sendromu. Yoğun Bakım Hemşireliği Dergisi.
108. Dehanov, S., & Ferreira, T. (2019). AN IMMACULATE CONCEPTION – THE DIFFERENTIAL DIAGNOSIS OF A DELUSION OF PREGNANCY. https://doi.org/10.26226/morressier.5d1a037857558b317a14085a
109. Delcea, C. (2019). Dyspareunia in men. International Journal of Advanced Studies in Sexology. https://doi.org/10.46388/ijass.2019.12.11.120
110. Delcea, C. (2019). Sexual deviances. International Journal of Advanced Studies in Sexology. https://doi.org/10.46388/ijass.2019.12.119
111. Delgado, Y. O., Reyes, A. C., & Imas, Y. A. (2012). Trastorno por estrés agudo: Presentación de un caso. Cuadernos de Medicina Forense. https://doi.org/10.4321/s1135-76062012000100004
112. Derkach, T., Lifintseva, A. A., & Shtolde, N. (2018). Phenomenon of Uncertainty as a Subjective Experience. Clinical Psychology and Special Education. https://doi.org/10.17759/cpse.2018070101
113. Desai, G., Chaturvedi, S. K., & Bhugra, D. (2020). Cultural Spectrum of Chronic Pain and Somatization Syndromes. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190248253.003.0027
114. Devi, T. S., Sangeeta, M., Sorokhaibam, B., & Ranjan, R. (2021). Reflection of Stress in the Oral Cavity. Indian Journal of Forensic Medicine & Toxicology. https://doi.org/10.37506/ijfmt.v15i1.13399
115. Dickerson, B. C., & Sperling, R. A. (2007). Dementia: mild cognitive impairment and Alzheimer’s disease. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198566298.003.0005
116. Diefenbach, G. J., & Goethe, J. W. (2006). Clinical interventions for late-life anxious depression. Clinical Interventions in Aging. https://doi.org/10.2147/ciia.2006.1.1.41
117. Dilsaver, S. C., Votolato, N. A., & Coffman, J. A. (1988). Depression in medical practice.. PubMed.
118. Ding, K., Song, Y., Zongyi, S., & Xinzhen, M. (2015). zhu jiang lu hang guan bing zhi ye juan dai xian zhuang ji ying xiang yin su yan jiu. Medical Journal of National Defending Forces in Northwest China.
119. DM, F. P. G. M., BSc, M. P. C. B., Boyd, D. M., & BSc, M. D. S. S. (2014). Major Medical Problems. https://doi.org/10.1002/9781118690345.ch8
120. Doblado, S. R., Zabala, M. B. E., Abascal, B. F., & Pelegrin, R. (2003). Síndrome depresivo en artritis reumatoide.
121. Docherty, J. P. (1997). Barriers to the diagnosis of depression in primary care.. PubMed.
122. Dodd, M. L. (2007). BASIC PRINCIPLES OF PSYCHIATRY. CRC Press eBooks. https://doi.org/10.1201/b14430-11
123. Dodick, D. W., & Roarke, M. C. (2007). Familial Hemiplegic Migraine: Permanent Attack‐Related Neurologic Deficits. Headache The Journal of Head and Face Pain. https://doi.org/10.1111/j.1526-4610.2007.00889.x
124. Dols, A., Rhebergen, D., Eikelenboom, P., & Stek, M. L. (2010). Melancholie; verstoorde beweging of ontstemd gemoed?. Tijdschrift voor psychiatrie.
125. Dreyer-Oren, S. E., Mitnaul, L., & Holtzheimer, P. E. (2018). Mood Disorders. American Psychiatric Association Publishing eBooks. https://doi.org/10.1176/appi.books.9781615372423.sy25
126. Drobizhev, М. Y., Galstyan, G. R., Surkova, E. V., Mel'nikova, O. G., & Divisenko, S. I. (2007). [Pain in diabetic neuropathy: psychosomatic aspects].. PubMed. https://doi.org/10.14341/probl200753643-47
127. Drossman, D. A. (1997). Irritable bowel syndrome and sexual/physical abuse history. European Journal of Gastroenterology & Hepatology. https://doi.org/10.1097/00042737-199704000-00002
128. Duarte, N. D. S., Corrêa, L. M. D. A., Assunção, L. R., Menezes, A. A. D., Castro, O. B. D., & Teixeira, L. F. (2017). Relation between Depression and Hormonal Dysregulation. Open Journal of Depression. https://doi.org/10.4236/ojd.2017.63005
129. Dubovsky, S., & Thomas, M. P. (1992). Psychotic Depression: Advances in Conceptualization and Treatment. Psychiatric Services. https://doi.org/10.1176/ps.43.12.1189
130. Ducrocq, F., & Vaïva, G. (2010). [From stress to post traumatic stress disorder].. PubMed.
131. Dudek, D., & Sobański, J. A. (2012). Mental disorders in somatic diseases: psychopathology and treatment. Polskie Archiwum Medycyny Wewnętrznej. https://doi.org/10.20452/pamw.1539
132. Dugué, S. (2020). Les spécificités du syndrome douloureux régional complexe de type 1 (SDRC 1) en pédiatrie. Douleur et Analgésie. https://doi.org/10.3166/dea-2020-0141
133. Duval, F., Lebowitz, B. D., & Macher, J. (2006). Treatments in depression. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2006.8.2/fduval
134. Dziegielewski, S. F. (2014). Depressive Disorders. https://doi.org/10.1002/9781394260577.ch7
135. D’cruz, M., Andrade, C., & Rao, T. S. (2020). The Expression of Intimacy and Sexuality in Persons With Dementia. Journal of Psychosexual Health. https://doi.org/10.1177/2631831820972859
136. Eames, P. E., & Wood, R. L. (2003). Episodic disorders of behaviour and affect after acquired brain injury. Neuropsychological Rehabilitation. https://doi.org/10.1080/09602010244000435
137. Ebenezer, I. S. (2015). Affective Disorders 1: Depression. https://doi.org/10.1002/9781118385777.ch6
138. Engel, G. L. (1968). A Life Setting Conducive to Illness. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-69-2-293
139. Espinel, Z., & Shaw, J. A. (2018). PTSD in Children. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190259440.003.0012
140. Evans, M., Copeland, J. R. M., & Dewey, M. (1991). Depression in the elderly in the community: Effect of physical illness and selected social factors. International Journal of Geriatric Psychiatry. https://doi.org/10.1002/gps.930061106
141. Familoni, O. B. (2008). An overview of stress in medical practice.. PubMed.
142. Faravelli, C., Zucchi, T., Perone, A., Salmoria, R., & Viviani, B. (2001). Social Phobia. https://doi.org/10.1002/0470846437.ch7
143. Fennell, T. B. A. M. J. V. (2008). Mindfulness-Based Cognitive Therapy: preventing relapse in depression. https://doi.org/10.4324/9780203884683-8
144. Fernández, A. A., Martín, Á. P., Martínez, M. I., Bustillo, M. A., Hernández, F. B., Labrado, J. D. L. C., Peñas, R. D.-D., Rivas, E. G., Delgado, C. P., Redondo, J. R., & Giménez, J. R. R. (2009). Chronic fatigue syndrome: aetiology, diagnosis and treatment. BMC Psychiatry. https://doi.org/10.1186/1471-244x-9-s1-s1
145. Fiar, Z., Hroudov, J., & Raboch, J. (2012). Neurotransmission in Mood Disorders. InTech eBooks. https://doi.org/10.5772/31831
146. Filipa, N., & Sergio, S. (2015). Phenomenology of Depression in Alzheimer's Disease. Advances in Alzheimer's disease. https://doi.org/10.3233/978-1-61499-542-5-3
147. Filipenka, H. (2021). Major depressive disorder..
148. Finch, S. M. (1975). Psychophysiologic Disorders in Children and Adolescents. The International Journal of Psychiatry in Medicine. https://doi.org/10.2190/wb9j-x63e-0jxu-4htt
149. Fink, M. (2010). Depressive Mood Disorders. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780195365740.003.0009
150. Fink, P. (2005). None. Tidsskrift for Forskning i Sygdom og Samfund. https://doi.org/10.7146/tfss.v3i5.495
151. Finsterer, J., & Zarrouk‐Mahjoub, S. (2013). Fatigue in Healthy and Diseased Individuals. American Journal of Hospice and Palliative Medicine®. https://doi.org/10.1177/1049909113494748
152. Fisher, A. D., Bandini, E., Casale, H., & Maggi, M. (2011). Paraphilic Disorders: Diagnosis and Treatment. https://doi.org/10.1002/9781119963820.ch8
153. Fitten, L. J. (2015). Psychological Frailty in the Aging Patient. Nestlé Nutrition Institute Workshop series. https://doi.org/10.1159/000382060
154. FM, P., & FP, J. (2015). Persistent Genital Arousal Disorder as a Dissociative Trauma Related Condition Treated with Brainspotting A Successful Case Report. International Journal of School and Cognitive Psychology. https://doi.org/10.4172/2469-9837.1000s1-002
155. Foa, E. B., Stein, D. J., & McFarlane, A. C. (2006). Symptomatology and psychopathology of mental health problems after disaster.. PubMed.
156. Fonseca, R. S. D., Nazaré, G. O. D., Silva, P. S. L. D., Fortes, G. N., & Lemos, A. L. (2017). SINTOMAS DEPRESSIVOS EM ACADÊMICOS DE UMA UNIVERSIDADE PÚBLICA NO OESTE DO ESTADO DO PARÁ, RELATO DE EXPERIÊNCIA. 13º Congresso Internacional Rede Unida.
157. Forster, F. M., Richards, J., Panitch, H., Huisman, R. E., & Paulsen, R. E. (1975). Reflex Epilepsy Evoked by Decision Making. Archives of Neurology. https://doi.org/10.1001/archneur.1975.00490430076015
158. Fox, H. M. (1942). DYNAMIC FACTORS IN THE AFFECTIVE PSYCHOSES. American Journal of Psychiatry. https://doi.org/10.1176/ajp.98.5.684
159. Frankenburg, F. R., & Zanarini, M. C. (2006). Personality disorders and medical comorbidity. Current Opinion in Psychiatry. https://doi.org/10.1097/01.yco.0000228766.33356.44
160. Friedhoff, A. J. (1992). Diagnosis and Treatment of Depression in Late Life. JAMA. https://doi.org/10.1001/jama.1992.03490080092032
161. Froehlich, L., Hattesohl, D. B. R., Cotler, J., Jason, L. A., Scheibenbogen, C., & Behrends, U. (2021). Causal attributions and perceived stigma for myalgic encephalomyelitis/chronic fatigue syndrome. Journal of Health Psychology. https://doi.org/10.1177/13591053211027631
162. Frémont, P. (2004). Aspects cliniques de la dépression du sujet âgé. Gériatrie et Psychologie Neuropsychiatrie du Viellissement.
163. Gameiro, G. R., Minguini, I. P., & Alves, T. C. T. F. (2014). O papel do estresse e de acontecimentos cotidianos para o desenvolvimento da depressão na terceira idade. Revista de Medicina. https://doi.org/10.11606/issn.1679-9836.v93i1p31-40
164. Ganasan, S. (2019). Managing depression in the primary care setting. Journal of Prescribing Practice. https://doi.org/10.12968/jprp.2019.1.8.388
165. Garay, M. A., Richards, S., Mj, M. U., & Luguercho, C. (2007). [Psychotic major depressive episode: target symptoms in males and females].. PubMed.
166. Garcia, M. O., Garnica, V. M., López, M. A., Leon, J. R. D., & Marín, S. G. (2017). Somatic-type delusional disorder and comorbidity mood disorder. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2017.01.353
167. García‐Soriano, G., & Martín, P. B. (2008). Trastornos del estado de ánimo al final de la vida: ¿desmoralización o depresión?. Revista de Psicopatología y Psicología Clínica. https://doi.org/10.5944/rppc.vol.13.num.2.2008.4055
168. Gatchel, R. J. (2019). Stress And Coping. Routledge eBooks. https://doi.org/10.4324/9781315002897-32
169. Geddes, J. (2000). Answering clinical questions about prognosis. Evidence-Based Mental Health. https://doi.org/10.1136/ebmh.3.4.100
170. Genazzani, A. D., Ricchieri, F., Lanzoni, C., Strucchi, C., & Jasonni, V. M. (2006). Diagnostic and Therapeutic Approach to Hypothalamic Amenorrhea. Annals of the New York Academy of Sciences. https://doi.org/10.1196/annals.1365.009
171. Gerc, K., & Makiełło-Jarzowa, G. (1998). [Psychological consequences of neurologic motor impairment from a developmental perspective].. PubMed.
172. Gerring, J. P. (1986). Psychiatric Sequelae of Severe Closed Head Injury. Pediatrics in Review. https://doi.org/10.1542/pir.8-4-115
173. Gifensius, J., Ganesha, I. G. H., Sundariyati, I. G. A. H., Tjandra, D. C., & Dewayani, I. A. P. (2024). THE INFLUENCE OF MENTAL HEALTH DISORDERS ON THE STUDENT COMPETENCY TEST FOR MEDICAL PROFESSIONAL PROGRAM (UKMPPD) RESULTS AT UDAYANA UNIVERSITY. E-Jurnal Medika Udayana. https://doi.org/10.24843/mu.2024.v13.i11.p17
174. Giovanni, A. D., Paolo, E. D., & Cuzzoni, G. (2013). Delirium ricorrente associato a blocco trifascicolare. Bollettino della Società Medico Chirurgica di Pavia. https://doi.org/10.6092/2039-1404.126.1601
175. Gold, B. G., Schnell, J. V., & Spencer, P. S. (2003). Neurotoxic Disorders. https://doi.org/10.1007/978-1-4757-4552-8_14
176. Gold, P. W. (2024). Depression: A malady of the self, arising from stress responses gone awry. Brain medicine :. https://doi.org/10.61373/bm024v.0022
177. Goldberg, R. J. (1993). Depression in medical patients.. PubMed.
178. Golec, A. S., Dobrogowski, J., & Kocot, M. (2000). [Psychological aspects of postop pain].. PubMed.
179. Gonda, X., Molnár, E., Torzsa, P., & Rihmer, Z. (2009). [Characteristics of depression in the elderly].. PubMed.
180. González, C., Betés, M., López‐Muñoz, F., & Martín, J. D. D. M. (2011). Aportaciones de la psicofarmacología al tratamiento de los trastornos de la personalidad (II) = Contributions of psychopharmacology for the treatment of personality disorders (II: grupos farmacológicos empleados en el tratamiento de los trastornos de personalidad = pharmacological groups employed in the treatment of the disorders of personality /. Edupsykhé Revista de Psicología y Educación. https://doi.org/10.57087/edupsykhe.v10i2.3852
181. González, M. J., Bardanca, M. S. G., Vivanco, E. F., Paz, M. T. A., & Allegue, M. D. (2007). Distonía psicógena: un diagnóstico complejo..
182. Goodin, D. S. (2006). Physical Trauma, Psychological Stress, and Multiple Sclerosis. https://doi.org/10.1093/oso/9780195170320.003.0037
183. Goodwin, G. M. (2006). Depression and associated physical diseases and symptoms. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2006.8.2/mgoodwin
184. Gordillo, R., Muñoz, L. H., López, E. S., Hernández, M. J., Borreguero, P. M., Méndez, M. A. R., Sánchez, V., Granados, T. G., & Burgos, R. I. Q. (2010). Trastorno bipolar en la infancia de causa orgánica. Revista de Psiquiatría Infanto-Juvenil.
185. Goron, S. (2017). La dépression postnatale, un phénomène dépressif atypique? : analyse des critères de sévérité de la symptomatologie et de la spécificité des symptômes et des causes.
186. Grabowska–Grzyb, A. (2005). Zaburzenia psychiczne w padaczce. Polski Przegląd Neurologiczny.
187. Grahovac, T., Ružić, K., Radonja, A. P., Knez, R., & Dadić-Hero, E. (2011). Symptom- diagnostic dilema. European Psychiatry. https://doi.org/10.1016/s0924-9338(11)72906-6
188. Grandner, M. A., & Perlis, M. L. (2015). Treating Insomnia Disorder in the Context of Medical and Psychiatric Comorbidities. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2015.3015
189. Greden, J. F. (2003). Physical symptoms of depression: unmet needs.. PubMed.
190. Green, S. A. (1996). Office psychotherapy for depression in the primary care setting. The American Journal of Medicine. https://doi.org/10.1016/s0002-9343(96)00396-8
191. Gregory, D. G. (2014). Post-Traumatic Stress Disorder: A Primer.
192. Griswold, K., Regno, P. A. D., & Berger, R. C. (2015). Recognition and Differential Diagnosis of Psychosis in Primary Care.. PubMed.
193. Group, M. T., Mackway‐Jones, K., Marsden, J., & Windle, J. (2006). Discriminator Dictionary. https://doi.org/10.1002/9780470757321.oth3
194. Gründer, G. (2006). Remission bei Depression erreichen. psychoneuro. https://doi.org/10.1055/s-2006-934199
195. Guerdjikova, A. I., McElroy, S. L., Barger, S. D., Barth, J., Farrelly, S., & Brohan, E. (2019). Recent Advances in Depressive Disorder.
196. Guskiewicz, K. M., & Goldman, S. B. (2013). A Changing Landscape: Traumatic Brain Injury in Military Combat and Civilian Athletics. The FASEB Journal. https://doi.org/10.1096/fj.13-1101ufm
197. Guthrie, E., & Nayak, A. (2012). Medically unexplained symptoms.
198. Guthrie, M., Zubatsky, M., & Smith, C. W. (2015). Family Stress and Counseling. Family Medicine. https://doi.org/10.1007/978-1-4939-0779-3_30-1
199. Halvorsen, H. T., Hammer, S. K., Nystrøm, V., & Leonardsen, A. L. (2019). Delirium hos intuberte intensivpasienter. iNSPIRA. https://doi.org/10.23865/inspira.v14.2784
200. Hansenne, M., Kjiri, K., Ajamieh, A., & Ansseau, M. (1998). [Clinical case of the month. A case of Munchausen syndrome (factitious disorder)].. PubMed.
201. Hartman, T. O., Dowrick, C., Lam, C. L. K., Fortes, S., Clarke, D. D., & Usta, J. (2019). Medically unexplained symptoms. Routledge eBooks. https://doi.org/10.4324/9780429026386-4
202. Hartung, P. J., & Penn, M. A. (2004). Work Stress and Health. https://doi.org/10.1093/oso/9780195149395.003.0041
203. Hasanat, N. U., & Ma, S. (2015). Pengembangan Modul untuk Meningkatkan Emosi Positif Pasien di Rumah Sakit. Buletin Psikologi. https://doi.org/10.22146/bpsi.7446
204. Hawes, D. J., & Scalise, P. (2005). Childhood depression: early risk and resilience and introducing solids to infants. https://doi.org/10.4225/50/5552facc15227
205. Hellhammer, D. H., & Wade, S. E. (1993). Endocrine Correlates of Stress Vulnerability. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000288675
206. Hermanns, N., Kulzer, B., & Krichbaum, M. (2014). Diabetes und Depressionen – Eine fatale Kombination. Diabetes aktuell. https://doi.org/10.1055/s-0034-1378124
207. Herpertz, S. C., & Saß, H. (2000). Emotional deficiency and psychopathy. Behavioral Sciences & the Law. https://doi.org/10.1002/1099-0798(200010)18:5<567::aid-bsl410>3.0.co;2-8
208. Hg, K. (1991). Depressive disorders in older medical inpatients.. American family physician.
209. Hiroaki, N., & Kubo, C. (2001). [The characteristics and mechanism of onset of abnormal eating behavior due to stress or psychosomatic diseases].. PubMed.
210. Hirsch, A. R. (2018). Chemosensory Malingering. CRC Press eBooks. https://doi.org/10.1201/9781351059633-11
211. Holden, K., & Isaac, C. L. (2011). Depression in Multiple Sclerosis: Reactive or Endogenous?. The Clinical Neuropsychologist. https://doi.org/10.1080/13854046.2011.564208
212. Holmes, A., Christelis, N., & Arnold, C. (2013). Depression and chronic pain. The Medical Journal of Australia. https://doi.org/10.5694/mja12.10589
213. Hong, C. (2013). 분과 심포지움 2. 임상 : 새로운 진단체계 DSM-5; 조현병 스펙트럼 및 기타 정신병적 장애,성격장애. 한국심리학회 연차 학술발표논문집.
214. Hong, C. (2013). 조현병 스펙트럼 및 기타 정신병적 장애, 성격장애. 한국심리학회 학술대회 자료집.
215. House, A. (1996). Depression associated with stroke. Journal of Neuropsychiatry. https://doi.org/10.1176/jnp.8.4.453
216. Huda, A. S. (2019). Biological factors and health. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198807254.003.0012
217. Huda, A. S. (2019). Social factors and health. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198807254.003.0013
218. Huda, A. S. (2019). Spectrums of conditions. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198807254.003.0011
219. Huda, A. S. (2019). Spectrums of health. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198807254.003.0009
220. Huda, A. S. (2019). Variability of clinical picture. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198807254.003.0010
221. Hughes, M. M., Connor, T. J., & Harkin, A. (2016). Stress-Related Immune Markers in Depression: Implications for Treatment. The International Journal of Neuropsychopharmacology. https://doi.org/10.1093/ijnp/pyw001
222. Hutton, J. L., Hunter, M. S., Jarrett, S., & Zoysa, N. D. (2014). CBT with People with Long‐Term Medical Conditions. https://doi.org/10.1002/9781394266487.ch11
223. Hybels, C. F., Blazer, D. G., & Steffens, D. C. (2006). Partial remission. A common outcome in older adults treated for major depression.. PubMed.
224. Iacob, V. T., Cămănaru, E., Moroșan, A., Moroșan, G., & Chiriță, R. (2023). Factitious disorders - a clinical and therapeutic challenge. Bulletin of Integrative Psychiatry. https://doi.org/10.36219/bpi.2023.3.07
225. Iliev, B., & Pavlovska, I. (2021). Analysis of Clinical Features of Patients with Depressive Disorder. Journal of Health Medicine and Nursing. https://doi.org/10.7176/jhmn/92-01
226. Imaduddin, R. R. (2019). Post Traumatic Stress Disorder Pada Korban Bencana. https://doi.org/10.35816/jiskh.v10i2.141
227. Impey, B., Gordon, R. P., & Baldwin, D. S. (2020). Anxiety disorders, post-traumatic stress disorder, and obsessive–compulsive disorder. Medicine. https://doi.org/10.1016/j.mpmed.2020.08.005
228. Ingrassia, G. F. (2012). HISTORICAL EVOLUTION OF MEDICAL KNOWLEDGE IN THE FIELD OF VEGETATIVE STATE.
229. Iqbal, R. K. (2019). Delirium: An Acute Confusional State. Annals of Advanced Biomedical Sciences. https://doi.org/10.23880/aabsc-16000132
230. Iqbal, R. K. (2019). Hallucination: Delusion Disorder. Psychology & Psychological Research International Journal. https://doi.org/10.23880/pprij-16000209
231. Irom, B. S. (2020). Is Mental Health Condition a Cause of Anxiety. Journal of Traumatic Stress Disorders & Treatment. https://doi.org/10.37532/2324-8947.2020.9(6).217
232. Is, B., Golovoda, A., Pneumaticos, S. G., & Vlamis, J. (2021). The effect of depression in hospitalization and rehabilitation of patients with spinal cord injury. Acta Orthopaedica Et Traumatologica Hellenica.
233. Isenberg, K., & Garcia, K. S. (2008). Syndromes of Brain Dysfunction Presenting with Cognitive Impairment or Behavioral Disturbance: Delirium, Dementia, and Mental Disorders Caused by a General Medical Condition. Humana Press eBooks. https://doi.org/10.1007/978-1-59745-252-6_2
234. Ishizuka, K., Shikino, K., Li, Y., Yokokawa, D., Tsukamoto, T., Yanagita, Y., Kojima, J., Yamashita, S., Noda, K., Uehara, T., & Ikusaka, M. (2023). The differential diagnosis of medical and psychogenic disease in primary care. Journal of General and Family Medicine. https://doi.org/10.1002/jgf2.661
235. Jain, S., Goel, S., & Kapila, S. (2015). Clinical Evaluation Of Psychiatric Emergencies.
236. Jean-Bay, E. (2000). The Biobehavioral Correlates of Post-traumatic Brain Injury Depression. Journal of Neuroscience Nursing. https://doi.org/10.1097/01376517-200006000-00009
237. Johnson, M. H. (2001). Assessing confused patients.. PubMed. https://doi.org/10.1136/jnnp.71.suppl_1.i7
238. Jorge, T. P. C. (2012). Fisiopatología del dolor agudo: alteraciones cardiovasculares, respiratorias y de otros sistemas y órganos.
239. Jovell, A. J. (2007). [Nursing based on affectivity].. PubMed.
240. Jp, O., Petitjean, F., & Deniker, P. (1981). [Masked depression and paucisymptomatic depression (author's transl)].. PubMed.
241. Juruena, M. F. (2012). Understanding subthreshold depression.. PubMed. https://doi.org/10.3969/j.issn.1002-0829.2012.05.009
242. Kai, K., Zhang, Jianguo, Wang, & Zhongcheng (2006). Deep brain stimulation in the treatment of tardive dystonia. 中华医学杂志：英文版.
243. Kakunje, A., & Rao, T. S. (2017). Making sense of the role of sense organs in trichotillomania. Indian Journal of Psychiatry. https://doi.org/10.4103/0019-5545.210740
244. Kales, H. C., & Valenstein, M. (2002). Complexity in Late-Life Depression: Impact of Confounding Factors on Diagnosis, Treatment, and Outcomes. Journal of Geriatric Psychiatry and Neurology. https://doi.org/10.1177/089198870201500306
245. Kalra, S., Verma, K., & Balhara, Y. P. S. (2017). Thyro-stress. Indian Journal of Endocrinology and Metabolism. https://doi.org/10.4103/ijem.ijem_136_17
246. Kapfhammer, H. (2006). Somatic symptoms in depression. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2006.8.2/hpkapfhammer
247. Kapfhammer, H. (2011). CS03-04 - Concept of somatoform disorder. European Psychiatry. https://doi.org/10.1016/s0924-9338(11)73481-2
248. Kasatkin, D. S. (2006). [Possible mechanisms of chronic fatigue syndrome in multiple sclerosis].. PubMed.
249. Katz, J., Rosenbloom, B. N., & Fashler, S. (2015). Chronic Pain, Psychopathology, and DSM-5 Somatic Symptom Disorder. The Canadian Journal of Psychiatry. https://doi.org/10.1177/070674371506000402
250. Keen, E. (2002). Depression. Praeger eBooks. https://doi.org/10.5040/9798400639272
251. Kelly, F. D. (2010). Adjustment Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0015
252. Kennedy, J. E., Jaffee, M. S., & Cooper, D. (2013). Posttraumatic Stress Disorder. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625154.da08
253. Kerfoot, M. (2005). Partnerships between health and local authorities. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198508441.003.0008
254. Kilalic, D. (2014). Burnout - psychologisches Konstrukt oder chronisch entzündliche Erkrankung.
255. Kim, G.-M., Jeong, W., & Hwang, T. (2019). Depression and Gap between Perceived- and Self-Willingness-to-Pay for Labor in Community-Dwelling Full-Time Female Homemakers. Journal of Korean Neuropsychiatric Association. https://doi.org/10.4306/jknpa.2019.58.4.322
256. Kim, S.-H., & Jung, S.-W. (2011). Psychiatric Approach of Fibromyalgia. Journal of Rheumatic Diseases. https://doi.org/10.4078/jrd.2011.18.4.242
257. Klein, D. F., & Wender, P. H. (2005). Symptoms of Mood Disorders: Recognizing Biological Depression. https://doi.org/10.1093/oso/9780195156133.003.0002
258. Klein, S. (2015). Autistic phenomena in neurotic patients 1. Routledge eBooks. https://doi.org/10.4324/9781315743882-10
259. Klembovskaya, E., & Fastovtsov, G. (2009). Clinical Content of Schizotypal Personality Disorder. European Psychiatry. https://doi.org/10.1016/s0924-9338(09)71387-2
260. Klerman, G. L., & Hirschfeld, R. M. A. (1978). The Use of Antidepressants in Clinical Practice. JAMA. https://doi.org/10.1001/jama.1978.03290130097036
261. Kmieciak, B., & Kowalski, M. (2017). Rodzina wobec prawnych problemów ochrony zdrowia psychicznego. Wybrane zagadnienia. Roczniki Pedagogiczne. https://doi.org/10.18290/rped.2017.9.4-5
262. Kocsis, J. H., & Brody, B. D. (2013). Chronic depression. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781139175869.010
263. Kokurenkova, P. A., Ilyichev, A. B., Grechanyy, S. V., Pozdnyak, V. V., & Khutoryanskaya, Y. V. (2020). Psychogenic dysuria. Pediatrician (St Petersburg). https://doi.org/10.17816/ped11573-79
264. Komaroff, A. L. (2017). Inflammation correlates with symptoms in chronic fatigue syndrome. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1712475114
265. Korff, M. V., & Simon, G. (1996). The Relationship Between Pain and Depression. The British Journal of Psychiatry. https://doi.org/10.1192/s0007125000298474
266. Kotade, K. B., Pandit, B. S., Gaware, V. M., Dolas, R. T., Dhamak, K. B., Somwanshi, S. B., Nikam, V. K., & Khadse, A. N. (2011). KNOWING DEPRESSION AND PHARMACOLOGICAL, NON-PHARMACOLOGICAL APPROACHES FOR ITS TREATMENT.
267. Krahn, L. E., MD, & Jowsey‐Gregoire, S. G. (2006). Psychiatry. CRC Press eBooks. https://doi.org/10.1201/b21610-26
268. Krahn, L. E., MD, & Jowsey‐Gregoire, S. G. (2007). Psychiatry. CRC Press eBooks. https://doi.org/10.1201/b14442-26
269. Krivić, D. (2018). UTJECAJ TRAUMATSKIH ISKUSTAVA IZ RANOG DJETINJSTVA NA KOGNITIVNE I PONAŠAJNE RAZVOJNE ISHODE.
270. Kröber, H. (2016). Mental illness versus mental disorder: Arguments and forensic implications. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198722373.003.0011
271. Kumar, R., & Kumar, R. (2006). Chronic Fatigue Syndrome. Apollo Medicine. https://doi.org/10.1016/s0976-0016(11)60212-3
272. Kunihiro, T., Soma, K., & Nakai, K. (2011). Cerebrospinal fluid leakage in a patient with depression: pre-existing depression may complicate the clinical picture of this complex syndrome. Equilibrium Research. https://doi.org/10.3757/jser.70.489
273. Kuriakose, T. (2013). Effectiveness of Speech Therapy in Neurogenic Stuttering: A Case Study.
274. Kutlubaev, M. A. (2017). Depression and depression-related disorders after a subarachnoid hemorrhage. S S Korsakov Journal of Neurology and Psychiatry. https://doi.org/10.17116/jnevro20171178220-26
275. Lacerda, S. A. D. (2017). None. MOJ Gerontology & Geriatrics. https://doi.org/10.15406/mojgg.1.2
276. Lafortune, G., Richardson, D., Sassi, F., Cecchini, M., Looper, M. D., Fujisawa, R., Dumont, J., Paris, V., Balestat, G., Notzon, F., Brownwood, I., Sandra, G., Armesto, N., Klazinga, S., Morgan, D., Astolfi, R., & Cave, W. (2009). Suicide. Health at a glance. https://doi.org/10.1787/health_glance-2009-9-en
277. Lahey, B. B. (2021). Conceptualizing Psychological Problems. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197607909.003.0001
278. Lahey, B. B. (2021). Dimensions of Externalizing Problems. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197607909.003.0004
279. Langlois, S. (2011). Un diagnostic "psy" invisible : le cas du trouble d'adaptation.
280. Larsen, R. J., Buss, D. M., Wismeijer, A., Song, J., Berg, S. M. V. D., & Jeronimus, B. F. (2021). Disorders of Personality.
281. Lattanzi, S., & Provinciali, L. (2015). Topical Lidocaine for Localized Neuropathic Pain. Archives of Neuroscience. https://doi.org/10.5812/archneurosci.28698
282. Lauriat, T. L., & Samson, J. (2015). Endocrine Disorders Associated with Psychological/Behavioral Problems. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780199352722.013.32
283. Leiblum, S. R. (2003). Arousal disorders in women: complaints and complexities. The Medical Journal of Australia. https://doi.org/10.5694/j.1326-5377.2003.tb05392.x
284. Leiby, A., & Chitkara, D. K. (2012). Functional Dyspepsia. Humana Press eBooks. https://doi.org/10.1007/978-1-60761-709-9_33
285. Leiguarda, R. (2003). Distinctive Features of Apraxia in Corticobasal Degeneration and Other Neurological Illnesses. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-326-2_10
286. Leite, J. P. R., Rodrigues, L. S., Mendes, G. M. G., Feitosa, K. A., Moraes, A. T. D., Teixeira, H. M., Costa, K. V. F. M. D., Paiva, M. C., Guirau, G. R., Almeida, T. M. D. S. D., Miranda, V. H. S., & Coelho, M. L. (2024). PHYSICAL EXERCISE REFLEXES IN PATIENTS OF DEPRESSIVE DISORDER. International Journal of Health Science. https://doi.org/10.22533/at.ed.1594592426062
287. Lembeck, M. A., Grønlund, C., Djurhuus, B. D., Lindelof, M., & Holm, E. (2021). The chronically dizzy patient. Ugeskrift for Læger.
288. Lemogne, C., Pitron, Jy, R., Limosin, F., & Cathébras, P. (2019). What attitude towards a patient with somatoform disorder?. PubMed.
289. Lennon, M. C., & Limonic, L. (2009). Work and Unemployment as Stressors. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511984945.015
290. Leong, G. B., Silva, J. A., & Weinstock, R. (2009). Delusions. Wiley Encyclopedia of Forensic Science. https://doi.org/10.1002/9780470061589.fsa256
291. Li, H., Braga, M. F. M., Hough, C., Manion, S. T., Jiang, X., Chen, A., Gamble, E. H., Abraham, P., & Anderjaska, V. (2005). Neuroplasticity and Calcium Signaling in Stressed Rat Amygdala. https://doi.org/10.21236/ada435451
292. Li, M., Rosenblat, J. D., & Rodin, G. (2018). Depression. American Psychiatric Association Publishing eBooks. https://doi.org/10.1176/appi.books.9781615371990.jl07
293. Lilienfeld, S. O., & Latzman, R. D. (2018). Personality disorders: Current scientific status and ongoing controversies.. American Psychological Association eBooks. https://doi.org/10.1037/0000064-023
294. Lim, E. C., & Seet, R. C. (2007). What is the place for placebo in the management of psychogenic disease?. Journal of the Royal Society of Medicine. https://doi.org/10.1177/014107680710000202
295. Lim, W. J., & Kaisbain, N. (2022). Emotional Stress Induced Broken Heart Syndrome: A Case Report. Cureus. https://doi.org/10.7759/cureus.32384
296. Littner, M. R., Hirshkowitz, M., Kramer, M., Kapen, S., Anderson, W. M., Bailey, D. R., Berry, R. B., Davila, D., Johnson, S., Kushida, C. A., Loube, D. I., Wise, M. S., & Woodson, B. T. (2003). An American Academy of Sleep Medicine Report Standards of Practice Committee of the American Academy of Sleep Medicine.
297. Littner, M. R., Hirshkowitz, M., Kramer, M., Kapen, S., Anderson, W. M., Bailey, D. R., Berry, R. B., Davila, D., Johnson, S., Kushida, C. A., Loube, D. I., Wise, M. S., & Woodson, B. T. (2003). Practice Parameters for Using Polysomnography to Evaluate Insomnia: An Update. SLEEP. https://doi.org/10.1093/sleep/26.6.754
298. Liu, S. (2011). Relationship Discussion between Emotional Factors and Chronic Fatigue Syndrome. Liaoning Zhongyiyao Daxue xuebao.
299. Liveson, J. A. (2000). Cramps and Fasciculations. https://doi.org/10.1093/oso/9780195135633.003.0041
300. Lloyd, G. (2007). Understanding psychological reactions to physical illness. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511543975.005
301. Lobo, I., Oliveira, L., David, I. A., Pereira, M. G., Volchan, E., Rocha-Rego, V., Figueira, I., & Mocaiber, I. (2011). The neurobiology of posttraumatic stress disorder: Dysfunction in the prefrontal-amygdala circuit?. Psychology & Neuroscience. https://doi.org/10.3922/j.psns.2011.2.004
302. Loriedo, C., & Jedlowski, M. (2011). Aspettative totalizzanti e relazioni familiari nella depressione. TERAPIA FAMILIARE. https://doi.org/10.3280/tf2010-094005
303. Loyola, D. P. (2010). Truques sensoriais em diferentes tipos de distonia e no espasmo hemifacial.
304. Lucchesi, L. M., Pradella-Hallinan, M., Lucchesi, M., & Moraes, W. A. D. S. (2005). O sono em transtornos psiquiátricos. Brazilian Journal of Psychiatry. https://doi.org/10.1590/s1516-44462005000500006
305. López, L., Solano, A., Aguirre, S., Osorio, C., & Trespalacios, E. M. V. (2012). El Estrés laboral y los trastornos psiquiátricos en profesionales de la medicina (Work Stress and psychiatric disorders in medical professionals) (Esporotricose: uma doença pouco conhecida ocupacional). CES Salud Pública.
306. López, O. I. F., Hernández, B. J., Almirall, R. B. A., Molina, D. S., & Navarro, J. R. C. (2012). Manual para diagnóstico y tratamiento de trastornos ansiosos. DOAJ (DOAJ: Directory of Open Access Journals).
307. López‐Jornet, P., Camacho‐Alonso, F., Andujar-Mateos, P., Sánchez‐Siles, M., & Gómez‐García, F. (2010). Burning mouth syndrome: An update. Medicina oral, patología oral y cirugía bucal. https://doi.org/10.4317/medoral.15.e562
308. MacGilvray, P., Williams, R., & Dambro, A. (2015). Anxiety Disorders. Family Medicine. https://doi.org/10.1007/978-1-4939-0779-3_32-1
309. Macneil, C., Hasty, M., Conus, P., Berk, M., & Scott, J. (2009). Social rhythm regulation. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511757389.008
310. Macovei, A. L., Dobrin, I., Chiriță, V., Burlui, A., Dobrin, P.-R., & Rezuş, E. (2019). Chronic fatigue and psychiatric comorbidities in patients with rheumatic disorders. Bulletin of Integrative Psychiatry. https://doi.org/10.36219/bpi.2019.03.08
311. Maddocks, I., & Macleod, A. D. (2018). Depression. CRC Press eBooks. https://doi.org/10.4324/9781315385532-8
312. Maercker, A. (2013). 2984 – Disorders specifically associated with stress. European Psychiatry. https://doi.org/10.1016/s0924-9338(13)77503-5
313. Malt, U. F., Malt, E. A., Blomhoff, S., & Refnin, I. (2002). [Functional somatic diseases--a review].. PubMed.
314. Manohar, S., Koolwal, A., & Rao, T. S. (2019). Sex and Depression. Journal of Psychosexual Health. https://doi.org/10.1177/2631831818821532
315. Manohar, S., Rao, T. S., Chandran, S., Maheshwari, S., George, M., Rao, S. S., & Sattar, F. A. (2017). Sexual Dysfunctions in Depression. Clinical Depression. https://doi.org/10.4172/2572-0791.1000125
316. Manotas, M. D. M. (2014). LA BIPOLARIDAD COMO UN TRASTORNO DEL ESTADO DE ÁNIMO EN EL SIGLO XXI. VISTO DESDE UNA PERSPECTIVA NEUROLÓGICA.
317. Mantelet, S., & Hardy, P. (2002). Dépression et maladies somatiques. MT. Médecine thérapeutique.
318. Marin, R. S. (1991). Apathy: a neuropsychiatric syndrome. Journal of Neuropsychiatry. https://doi.org/10.1176/jnp.3.3.243
319. Markham, R. A., & Watts, S. (2005). Etiology of Depression in Children.. Journal of instructional psychology.
320. Martins-Monteverde, C. M. S., Padovan, T., & Juruena, M. F. (2017). Trauma and stressor-related disorders. Medicina (Ribeirão Preto). https://doi.org/10.11606/issn.2176-7262.v50isupl1.p37-50
321. María, A., Sancho, R., & Pita, B. L. (2005). Trastornos de ansiedad en la infancia y en la adolescencia.
322. Masseret, É., Bauerheim, N., El‐Hage, W., Mercier, E., Guillon, A., & Dequin, P. (2012). État de stress post-traumatique après ventilation prolongée. Réanimation. https://doi.org/10.1007/s13546-012-0629-8
323. Mauri, M., & Ramacciotti, D. (2006). Sintomi Psichici e Somatici dei Disturbi dell'Umore: razionali di terapia. Giornale italiano di psicopatologia/Journal of psychopathology/Italian journal of psychopathology.
324. Mayer, E., Fass, R., & Fullerton, S. (1998). Intestinal and Extraintestinal Symptoms in Functional Gastrointestinal Disorders. The European Journal of Surgery. https://doi.org/10.1080/11024159850191201
325. Mazumdar, H., Haloi, N., & Mazumdar, M. (2011). Impact of job stress on urban and rural employees in Kamrup district, Assam (India): A physiological and psychological study.. Archives of applied science research.
326. McCullough, P. K. (1991). Geriatric depression: atypical presentations, hidden meanings.. PubMed.
327. McIntyre, R. S., Danielle, S., & Soczynska, J. K. (2014). Differentiating cognitive dysfunction from other dimensions of psychopathology in major depressive disorder. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199688807.003.0005
328. McKnight, R., Price, J., & Geddes, J. (2019). Introduction to psychiatry. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198754008.003.0005
329. McKnight, R., Price, J., & Geddes, J. (2019). Medically unexplained physical symptoms. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198754008.003.0033
330. McKnight, R., Price, J., & Geddes, J. (2019). People presenting with physical disorder. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198754008.003.0027
331. McKnight, R., Price, J., & Geddes, J. (2019). Reactions to stressful experiences. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198754008.003.0031
332. McKnight, R., Price, J., & Geddes, J. (2019). Sleep disorders. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198754008.003.0036
333. McVicar, K. (2006). Seizure-like States. Pediatrics in Review. https://doi.org/10.1542/pir.27-5-e42
334. McVicar, K. (2006). Seizure-like States. Pediatrics in Review. https://doi.org/10.1542/pir.27.5.e42
335. Medina, A. B., Roniger, D. D. G., Alonzo, G. M., & Genchi, A. J. (2012). Síndrome de piernas inquietas en comorbilidad con trastornos psiquiátricos y enfermedad médica: un caso ilustrativo. Psiquis - Hospital Psiquiátrico Fray Bernardino Alvarez.
336. Meeke, H. J. (2011). Hypochondriasis (Health Anxiety) Reformulated: Similarities With Generalized Anxiety Disorder in A Routine Setting Single Case.
337. Melville-Drewes, A. (2018). Posttraumatische Verbitterungsstörung, Burn-out ... – arbeitsplatzbezogene psychische Störungen in der amtsärztlichen Begutachtung. Das Gesundheitswesen. https://doi.org/10.1055/s-0038-1639183
338. Merlín, E. P.-R., González‐Forteza, C., Lira, L. R., & Tapia, J. A. J. (2007). Trastorno por estrés postraumático en pacientes con lesiones no intencionales producidas en accidentes de tránsito. Salud Mental.
339. Meyer, J. S., & Hamel, A. F. (2014). Models of Stress in Nonhuman Primates and Their Relevance for Human Psychopathology and Endocrine Dysfunction. ILAR Journal. https://doi.org/10.1093/ilar/ilu023
340. Michie, S. (2002). CAUSES AND MANAGEMENT OF STRESS AT WORK. Occupational and Environmental Medicine. https://doi.org/10.1136/oem.59.1.67
341. Mikkelsen, M. E., & Iwashyna, T. J. (2020). Persistent problems and recovery after critical illness. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0395
342. Mikkelsen, M. E., & Iwashyna, T. J. (2020). Persistent problems and recovery after critical illness. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0395_update_001
343. Miller, M. W., Marx, B. P., & Keane, T. M. (2010). Posttraumatic Stress Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0699
344. Mitropoulos, G. B. (2021). Being psychotic is not necessarily being ill: Psychotic continuum and the relevance of lacanian psychoanalytic approach. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2021.2127
345. Miyoshi, K. (2001). Depression Associated with Physical Illness.
346. Moch, S. (2011). Dysthymia: more than "minor".
347. Moch, S. (2011). Dysthymia: more than “minor” depression. South African Pharmaceutical Journal.
348. Montejo, Á. L., Montejo, L., & Baldwin, D. S. (2018). The impact of severe mental disorders and psychotropic medications on sexual health and its implications for clinical management. World Psychiatry. https://doi.org/10.1002/wps.20509
349. Moradi, A., Ebrahimzadeh, M. A., & Ring, D. (2013). Nonspecific arm pain.. PubMed.
350. Moreira, M. V., Silva, D. D. M., Carmo, P. F. D., Rabelo, R. B., Brito, K. T. D., Béda, N. S., Lopes, E. V. F., Barbosa, M. L. G., Dias, R. B. S., Araújo, I. E. S., Lino, A. J. G. B., & Santos, K. A. C. (2024). EFEITOS DO ESTRESSE NAS LESÕES BUCAIS: REVISÃO DE LITERATURA. Brazilian Journal of Implantology and Health Sciences. https://doi.org/10.36557/2674-8169.2024v6n7p1609-1617
351. Morin, C. (2009). [Sense of personal identity and focal brain lesions].. PubMed. https://doi.org/10.1684/pnv.2009.0156
352. Morylowska-Topolska, J., Ziemiński, R., Molas, A., Gajewski, J., Flis, M., Stelmach, E., & Karakuła‐Juchnowicz, H. (2016). Schizophrenia and anorexia nervosa – reciprocal relationships. A literature review. Psychiatria Polska. https://doi.org/10.12740/pp/onlinefirst/63514
353. Moser, G. (2009). Reizdarmsyndrom und Psychosomatik. Journal für Ernährungsmedizin.
354. Motta, M. P., Quadros, A. A. J., Ferreira, L. S., & Oliveira, A. S. B. (2019). Fatigue in Post-Polio Syndrome. Brazilian Journal of Biological Sciences. https://doi.org/10.21472/bjbs.061203
355. Mucci, A., Bucci, P., Giordano, G. M., Brando, F., & Galderisi, S. (2021). Apathy in schizophrenia: assessment in clinical settings and overlap with other dimensions of impairment. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2021.159
356. Mude, G., Pise, S., Makade, K., Fating, R., & Wakodkar, S. (2020). Potentiating effect of N. Jatamansi root extract by evaluating anti-depression and anxiolytic activity in rats. Journal of Pharmacognosy and Phytochemistry.
357. Myakotnykh, V. S., & Borovkova, T. A. (2017). [Syndrome of emotional burnout among women-physicians elderly].. PubMed.
358. Nahler, G. (2009). labelling phenomenon. Dictionary of Pharmaceutical Medicine. https://doi.org/10.1007/978-3-211-89836-9_767
359. Naidoo, S. (2015). Managing stress in the dental environment.
360. Nama, S., Matli, P., & Chengalva, T. K. (2015). Cross-Sectional Study on Stress, Anxiety and Depression among Medical Undergraduate Students of Guntur Medical College, AP, India. International Journal of Preventive Curative & Community Medicine.
361. Nandi, K., Sarkar, S., Bakshi, P., Chandra, A. C., Chakraborty, A., Mondal, S., Biswas, A., Bera, K., Sen, D. J., & Saha, D. (2005). COVID-19 & CO-MORBIDITY: DEMONIC FORCES THAT SUPRESS THE CIVILIZATION. World Journal of Pharmaceutical and life sciences.
362. Naranđa, F. S. (2019). Značaj Empty selle u procjeni funkcije hipofize.
363. Narayan, A. (2012). Post Traumatic Stress Disorder – An Overview. InTech eBooks. https://doi.org/10.5772/26012
364. Nasrallah, H. A. (2014). Borderline Personality Disorder Is a Heritable Brain Disease. Current psychiatry.
365. Nassisi, D., Korc, B., Hahn, S. A., Bruns, J., & Jagoda, A. (2006). The evaluation and management of the acutely agitated elderly patient.. PubMed.
366. Navarro, P. V., López, D. L., & Cárdenas, S. P. (2015). Estresores psicosociales y depresión mayor recurrente. Revista Salud Bosque. https://doi.org/10.18270/rsb.v1i2.94
367. Neeleman, J., & Mh, D. G. (2006). [Suicidal tendencies, a disorder that crosses boundaries between disciplines].. PubMed.
368. Nicholson, T. R., Carson, A., Edwards, M. J., Goldstein, L. H., Hallett, M., Mildon, B., Nielsen, G., Nicholson, C., Perez, D. L., Pick, S., Stone, J., Anderson, D. G., Asadi‐Pooya, A. A., Aybek, S., Baslet, G., Bloem, B., Brown, R. J., Chalder, T., Damianova, M., ... Tinazzi, M. (2019). Outcome Measures for Functional Neurological Disorder: A Review of the Theoretical Complexities. Journal of Neuropsychiatry. https://doi.org/10.1176/appi.neuropsych.19060128
369. Noyes, R., & Hoehn‐Saric, R. (1998). Anxiety in the medically ill: disorders due to medical conditions and substances. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511663222.008
370. Noyes, R., & Hoehn‐Saric, R. (1998). Social phobia. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511663222.005
371. Núñez-Moscoso, P., Natale-Guevara, M. D., Pomareda-Llanos, J., & Cruzado, L. (2017). Psicosis instrumental: a propósito de dos probables casos. Revista de Neuro-Psiquiatría. https://doi.org/10.20453/rnp.v79i4.2981
372. O'Keeffe, N., & Ranjith, G. (2007). Depression, demoralisation or adjustment disorder? Understanding emotional distress in the severely medically ill. Clinical Medicine. https://doi.org/10.7861/clinmedicine.7-5-478
373. Oh, S.-H. (2019). 12 - CAN RORSCHACH DIFFERENTIATE BIPOLAR DISORDER FROM DEPRESSIVE DISORDER? : COMPARISON OF RORSCHACH SCORES BETWEEN BIPOAR DEPRESSION AND UNIPOLAR DEPRESSION. https://doi.org/10.26226/morressier.5d1a038757558b317a13f97e
374. Olszewska, A., Daktera-Micker, A., Cieślińska, K., Firlej, E., & Biedziak, B. (2017). Auto-aggressive behavior in dental patients. Journal of Medical Science. https://doi.org/10.20883/jms.2017.210
375. Omurzakova, A., Abdurakhmanov, B., Abdykaiymova, G., Barbyshov, I., & Pranayee, R. (2024). STUDYING ATTITUDES TO DEPRESSION AMONG STUDENTS. Bulletin of Osh State University. https://doi.org/10.52754/16948610_2024_2_13
376. Os, J. V., Praag, H. M. V., & Kloet, E. R. D. (2004). Stress, the brain and depression. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544422.010
377. Ownby, R. L. (2006). Medication adherence and cognition. Medical, personal and economic factors influence level of adherence in older adults.. PubMed.
378. Ozdemir, D., & Sahni, S. (2019). Conversion Disorder (Functional Neurological Symptom Disorder) Masquerading as Multiple Sclerosis: A Case Report. Cureus. https://doi.org/10.7759/cureus.4893
379. O’Neil-Page, E., Anderson, P. R., & Dean, G. E. (2015). Fatigue. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190244330.003.0001
380. Pablo, G. S. D. (2018). Mental Capacity and Decision Making in Bipolar Disorder. Peer Reviewed Journal of Forensic & Genetic Sciences. https://doi.org/10.32474/prjfgs.2018.03.000152
381. Padmos, R. C. (2009). Inflammatory Monocytes in Bipolar Disorder and Related Endocrine Autoimmune Diseases.
382. Paiva, T. C. D., Soares, L., & Faria, A. L. (2023). Depression in Elderly People. Encyclopedia. https://doi.org/10.3390/encyclopedia3020048
383. Palmer, B. A. (2021). Personality and Illness. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197512166.003.0042
384. Pao, M., & Bosk, A. (2010). Anxiety in medically ill children/adolescents. Depression and Anxiety. https://doi.org/10.1002/da.20727
385. Paredes, D. F. D., Farfán, J. C. P., Orellana, J. M. F., & Legarda, A. A. B. (2019). Trastorno disfórico premenstrual. RECIAMUC. https://doi.org/10.26820/reciamuc/3.(1).enero.2019.199-217
386. Pariel-Madjlessi, S., Pouillon, M., Robcis, I., Sebban, C., Frémont, P., & Belmin, J. (2005). [Depression: an underrated consequence of stroke in elderly].. PubMed.
387. PARISER, S. F., Nasrallah, H. A., & Gardner, D. L. (1997). Postpartum Mood Disorders: Clinical Perspectives. Journal of women's health. https://doi.org/10.1089/jwh.1997.6.421
388. Parker, G., & Manicavasagar, V. (2005). Acute stress-related non-melancholic depression. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544194.014
389. Parker, G., & Manicavasagar, V. (2005). Chronic stress-related non-melancholic depression. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544194.016
390. Parker, G., & Manicavasagar, V. (2005). Identifying the constructs to non-melancholic depression: stress. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544194.011
391. Parmet, S., Burke, A. E., & Glass, R. M. (2006). Insomnia. JAMA. https://doi.org/10.1001/jama.295.24.2952
392. Pashov, A. (2018). Paradigm shift in rehabilitation of long-standing Bell’s palsy during later stages of recovery. Fundamental and applied researches in practice of leading scientific schools.
393. Patten, S. B. (2015). Major depressive disorder: reification and (maybe) rheostasis. Epidemiology and Psychiatric Sciences. https://doi.org/10.1017/s2045796015000682
394. Paulus, W. J., Reimers, C. D., & Steinhoff, B. J. (2000). Dystonien (unwillkürliche Muskelbewegungen). Steinkopff eBooks. https://doi.org/10.1007/978-3-642-57726-0_16
395. Peng, M. (2017). Diagnosis of medically unexplained dyspnea. BMJ. https://doi.org/10.3760/cma.j.issn.1671-7368.2017.11.001
396. Pereira, J. V., & Araújo, G. D. F. (2024). Depressão puerperal e seu difícil diagnóstico. Jornal Brasileiro de Ginecologia. https://doi.org/10.5327/jbg-2965-3711-2024134s1235
397. Perez‐Cruz, P. E., & Chittenden, E. (2015). Pharmacologic and Other Somatic Treatments of Dyspnea. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199731855.003.0027
398. Perrine, K. (1991). Psychopathology in Epilepsy. Seminars in Neurology. https://doi.org/10.1055/s-2008-1041219
399. Petermann, F. (2012). Beschwerdenvalidierung. Die Rehabilitation. https://doi.org/10.1055/s-0032-1323652
400. Petkar, S., Jackson, M., & Fitzpatrick, A. (2005). Management of blackouts and misdiagnosis of epilepsy and falls. Clinical Medicine. https://doi.org/10.7861/clinmedicine.5-5-514
401. Peveler, R. (2002). ABC of psychological medicine: Depression in medical patients. BMJ. https://doi.org/10.1136/bmj.325.7356.149
402. Peña, M. A. M. (2013). Síndrome de sobreentrenamiento. IATREIA.
403. Phan, S. (2013). Primary or secondary? What came first and how to treat?. Mental Health Clinician. https://doi.org/10.9740/mhc.n178411
404. Phillips, K. A. (2014). Body Dysmorphic Disorder. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg22
405. Pickard, H. (2011). What Is Personality Disorder?. Philosophy, psychiatry & psychology. https://doi.org/10.1353/ppp.2011.0040
406. Pignalberi, C., Ricci, R. P., & Santini, M. (2002). [Psychological stress and sudden death].. PubMed.
407. Polack, R. G., Siemer, M., & Joormann, J. (2024). Sadness and Depression. Routledge eBooks. https://doi.org/10.4324/9781003469018-21
408. Polanowska, K., & Seniów, J. (2005). Obraz kliniczny i diagnostyka zespołu zaniedbywania jednostronnego.
409. Pollack, M. H. (2001). Comorbidity, neurobiology, and pharmacotherapy of social anxiety disorder.. PubMed.
410. Poole, J., & Hardie, R. (2019). Neurological disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198808657.003.0023
411. Popa, T., & Delcea, C. (2019). Voyeurism and Scopophilia. International Journal of Advanced Studies in Sexology. https://doi.org/10.46388/ijass.2019.12.11.121
412. Portenoy, R. K., & Bruera, É. (2003). Depression in the Terminally Ill: Prevalence and Measurement Issues. Oxford University Press eBooks. https://doi.org/10.1093/acprof:oso/9780195130652.003.0012
413. Pottash, A. C. (1981). Depression and Abnormal Endocrinologic Tests-Reply. JAMA. https://doi.org/10.1001/jama.1981.03320180024019
414. Pozaić, A. (2018). Zdravstvena njega osoba oboljelih od poremećaja hranjenja.
415. Praag, H. M. V. (2004). The Debit Balance of Present Day Stress Research. The World Journal of Biological Psychiatry. https://doi.org/10.1080/15622970410029928
416. Pranjić, N., & Maleš-Bilić, L. (2015). [LOW BACK PAIN AT NEW WORKING AMBIENT IN ERA OF NEW ECONOMY: A SYSTEMATIC REVIEW ABOUT OCCUPATIONAL RISK FACTORS].. PubMed.
417. Pridmore, S. (2019). Mood and affect. Psychiatry and Clinical Neurosciences. https://doi.org/10.1111/pcn.12836
418. Qureshi, M. A., & Wasti, S. A. (2014). Lay-off Survivor Sickness Syndrome (Investigating the Lasting Impact on Performance of Survivors in the Context of Age and Gender in Private Sector Organizations of Pakistan). International Journal of Human Resource Studies. https://doi.org/10.5296/ijhrs.v4i3.6078
419. Rachmani, S., & Mayasari, D. (2017). Kombinasi Farmakoterapi dan Psikoterapi Pada Pengobatan Episode Depresif Sedang Dengan Gejala Somatis. Jurnal Medula.
420. Rai, R., & Pieters, T. (2013). An unusual psychiatric presentation of polycythaemia ‘Difficulties lie in our habits of thought rather than in the nature of things’ Andre Tardieu. BMJ Case Reports. https://doi.org/10.1136/bcr-2012-008215
421. Rajagopalan, J., & Rangaswamy, P. (2015). Conversion disorder in childhood presenting as movement disorder with severe injuries. Journal of Pediatric Neurology. https://doi.org/10.3233/jpn-120575
422. Rani, S., & Saini, D. S. (2015). Organizational Stress in Relation to Job Satisfaction and General Health of Professional Women. International journal of education and management studies.
423. Rapkin, A. J., & Mikacich, J. (2007). Clinical evaluation and management. CRC Press eBooks. https://doi.org/10.3109/9781435628168-19
424. Realpe, B. L. C. (2013). Estudio comparativo de la acción psicofarmacológica y analgésica de extractos de plantas de uso terapéutico tradicional con antidepresivos inhibidores selectivos de la recaptación de monoaminas.
425. Reeves, R. R., & Torres, R. (2003). Exacerbation of Psychosis by Misinterpretation of Physical Symptoms. Southern Medical Journal. https://doi.org/10.1097/01.smj.0000078686.34109.11
426. Reis, J. T., Silva, I., Borges, A. G. D. A., Reis, A. P. T. D., Santos, W. A. D. M., Benevides, K. A. M. M., Abreu, S. E., Moreno, T. S.-A., Almeida, J. Q., Mangueira, C. D. M., Vasconcelos, F. H., Mariano, W. D. S., & Sampaio, A. C. M. (2024). The Relationship between Depression and Chronic Pain: A Literature Review. Journal of Advances in Medicine and Medical Research. https://doi.org/10.9734/jammr/2024/v36i85548
427. Richardson, J. S. (2003). The Olfactory Bulbectomized Rat as a Model of Major Depressive Disorder. Humana Press eBooks. https://doi.org/10.1385/0-89603-177-2:61
428. Riemann, D., Zerssen, D. V., Berger, M., Dose, M., Doerr, P., Krieg, C. J., Bossert, S., Pirke, K. M., Dolhofer, R., & Müller, O. A. (1986). The nature of neuroendocrine abnormalities in depression: a controversial issue in contemporary psychiatry.. PubMed.
429. Ritchie, K. (2014). Late-life depression. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2014.09.272
430. Rm, T., Seth, P., Awasthi, P., Bhattacharya, A., Ak, B., & Thahriani, A. (2018). Psychosomatic disorders affecting the oral cavity: A review article. Deleted Journal.
431. Robinson, D. J., Coons, M. J., Haensel, H., Vallis, M., & Yale, J. (2018). Diabetes and Mental Health. Canadian Journal of Diabetes. https://doi.org/10.1016/j.jcjd.2017.10.031
432. Robinson, R. G. (1998). Treatment issues in poststroke depression. Depression and Anxiety. https://doi.org/10.1002/(sici)1520-6394(1998)8:1+<85::aid-da13>3.0.co;2-e
433. Robinson, R. G. (2006). Phenomenology and specificity of depressive symptoms. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544231.008
434. Rocha, C., Silva, G. C. D., Biângulo, K. S., Santos, L. D. D., Duarte, M. L. D. M., Melo, R. F. D., Silva, R. T. D., Galhardo, A. T., & Viana, F. M. (2024). DEPRESSÃO PÓS-PARTO. Editora Acadêmica Periodicojs eBooks. https://doi.org/10.51249/easn17.2024.1896
435. Rodríguez, S. P. G., & Maestre, M. Á. M. (2006). Menopausia y trastornos psicoafectivos. Ginecología y obstetricia clínica/Ginecología y obstetricia clínica.
436. Romaniv, O., & Pohoriliak, K. (2017). Сlinical case: social load is the predictor and preventer of somatization. Psychosomatic Medicine and General Practice. https://doi.org/10.26766/pmgp.v2i2.28
437. Rosenberg, D. L., & Latorre, J. G. (2015). Hearing One’s Voice in Your Speech. The Neurologist. https://doi.org/10.1097/nrl.0000000000000069
438. Rosenblat, J. D., Kurdyak, P., Cosci, F., Berk, M., Maes, M., Brunoni, A. R., Li, M., Rodin, G., McIntyre, R. S., & Carvalho, A. F. (2019). Depression in the medically ill. Australian & New Zealand Journal of Psychiatry. https://doi.org/10.1177/0004867419888576
439. Ross, D. L., & Hazlett, M. H. (2018). Assessing the symptoms associated with excited delirium syndrome and the use of conducted energy weapons. Forensic Research & Criminology International Journal. https://doi.org/10.15406/frcij.2018.06.00206
440. Ross, G. A. (2007). Outcomes of Smell. Cliniques méditerranéennes.
441. Rouillon, F., Delhommeau, L., & Vinceneux, P. (2012). Chronic Fatigue Syndrome. SpringerReference. https://doi.org/10.1007/springerreference_109252
442. Río, J. A. D. (2013). Incapacitación y drogodependencias.
443. Rüstemova, D., Genç, A., Bora, G., & Tur, B. S. (2017). A thermal dysregulation problem after breast cancer surgery; what could be?. Medicine. https://doi.org/10.1097/md.0000000000007027
444. Saadat-Gilani, K. (2005). Bedeutung opioiderger Signalwege für die Modulation viszeraler Afferenzen bei funktionellen Magendarmerkrankungen.
445. Sachdev, P. S. (2013). Posttraumatic Psychosis. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625154.da09
446. Sadiq, H., & Abakah, S. (2015). Depression and Its Relation with Blood Group According Differences (Sex).
447. Sahakian, B. J., & Morein‐Zamir, S. (2011). Depression and resilience: insights from cognitive, neuroimaging, and psychopharmacological studies. Oxford University Press eBooks. https://doi.org/10.1093/acprof:oso/9780199600434.003.0023
448. Sailesh, K. S., Archana, R., & Mukkadan, J. K. (2014). Controlled Vestibular Stimulation: A Traditional Intervention for Pre Menstrual Syndrome. JOURNAL OF CLINICAL AND BIOMEDICAL SCIENCES. https://doi.org/10.58739/jcbs/v04i4.7
449. Salcedo, A. K. M., Escobar, J. C. C., & Diaz, L. Y. V. (2019). Ansiedad dental en adultos en la clínica odontológica de la universidad cooperativa de colombia de pasto.
450. Salem, T., Winer, E. S., Bartoszek, G., & Snodgrass, M. (2015). Major Depressive Disorder. The Encyclopedia of Clinical Psychology. https://doi.org/10.1002/9781118625392.wbecp433
451. Sandi, C. (2013). Stress and cognition. Wiley Interdisciplinary Reviews Cognitive Science. https://doi.org/10.1002/wcs.1222
452. Santeusanio, F. (2012). Quadri internistici ed endocrinologici connessi alla disabilitŕ grave. CHILD DEVELOPMENT & DISABILITIES - SAGGI. https://doi.org/10.3280/cdd2010-003010
453. Savina, S., Chernicova, I., & Zaydiner, B. (2021). A Review on Depressive Disorders in Cancer Patients. Book Publisher International (a part of SCIENCEDOMAIN International). https://doi.org/10.9734/bpi/idhr/v3/12364d
454. Sayarifard, A., & Ghadirian, L. (2013). Mental health literacy in iran: an urgent need for a remedy.. PubMed.
455. Schad, J. N. (2015). Mental Stress; Brain’s Complexity Resolution Dilemma. Journal of Neurology & Stroke. https://doi.org/10.15406/jnsk.2015.02.00058
456. Schmitz, B. (2005). Depression and Mania in Patients with Epilepsy. Epilepsia. https://doi.org/10.1111/j.1528-1167.2005.463009.x
457. Schneider, L. S., & Abou‐Saleh, U. B. M. T. (2002). Neurochemistry. https://doi.org/10.1002/0470846410.ch72
458. Schröder, A., Høeg, M. D., & Fink, P. (2013). [Subjective dizziness].. PubMed.
459. Schäfer, I., Kurth, R., & Gerhardt, H. (2011). Posttraumatische und psychotische Symptome bei schwer traumatisierten Patienten. Fortschritte der Neurologie · Psychiatrie. https://doi.org/10.1055/s-0031-1281801
460. Scrivani, S. J., Dhadwal, S., Vyas, H., & Spierings, E. L. (2016). Facial Pain. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199315246.003.0043
461. Seah, M., & Khanduja, V. (2017). Hip disorders. CRC Press eBooks. https://doi.org/10.1201/9781315384030-6
462. Seemüller, F., Allwang, C., & Beraldi, A. (2019). Ist Burnout eine Folge des Arbeitslebens?. Nervenheilkunde. https://doi.org/10.1055/a-0876-9848
463. Segui, G., Marambio, J., Cortés, I., & Breinbauer, H. (2019). Mareo postural perceptual persistente: La causa más frecuente de mareo crónico es fácil de tratar. Revista de otorrinolaringología y cirugía de cabeza y cuello. https://doi.org/10.4067/s0718-48162019000300323
464. Sekhon, S., Patel, J., & Sapra, A. (2019). Late Onset Depression. StatPearls.
465. Selhub, E. M. (2002). Stress and Distress in Clinical Practice: A Mind‐Body Approach. Nutrition in Clinical Care. https://doi.org/10.1046/j.1523-5408.2002.00404.x
466. Sewell, R. D. E. (2018). Neuropathic pain models and outcome measures: a dual translational challenge. Annals of Translational Medicine. https://doi.org/10.21037/atm.2018.09.58
467. Sh., R., Akhmad, N., Zhunistaev, D., Jussipbekova, B., & Orazakiyeva, T. (2020). The Pancreatic Secretions are Under Conditions of Emotional Stress. Systematic Reviews in Pharmacy.
468. Shanmugaratnam, S., Shanmugaratnam, H., & Parisaei, M. M. (2013). Premenstrual syndrome. InnovAiT Education and inspiration for general practice. https://doi.org/10.1177/1755738012467442
469. Sharif, A. T. (2018). Effect of Stress on Academic Performance of Undergraduate Medical Students.
470. Sharma, R., & Sapra, U. K. (2019). DEPRESSION: AN AYURVEDIC REVIEW. International Journal of Research in Ayurveda and Pharmacy. https://doi.org/10.7897/2277-4343.100354
471. Sharp, L. K., & Lipsky, M. S. (2002). Screening for depression across the lifespan: a review of measures for use in primary care settings.. PubMed.
472. Sharpe, M., & Wessely, S. (2020). Psychological treatments. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0626
473. Sharpe, M., & Wilks, D. (2002). ABC of psychological medicine: Fatigue. BMJ. https://doi.org/10.1136/bmj.325.7362.480
474. Sherchan, S., & Joshi, D. (2015). The Man Behind the Royal Massacre. Journal of Nepal Medical Association. https://doi.org/10.31729/jnma.2749
475. Shukla, A., Singh, S. P., Srivastava, N., & Gupta, K. L. (2018). Major problem of today’s generations. International Journal of Pharmacological Research. https://doi.org/10.7439/ijpr.v8i2.4613
476. Siddiqui, J. A., Qureshi, S. F., & Ghamdi, A. K. A. (2017). Alien Abductions: A Case of Sleep Paralysis. Sleep and Hypnosis. https://doi.org/10.5350/sleep.hypn.2017.19.0144
477. Siennicka, A., Strömberg, A., Banasiak, W., Ponikowski, P., & Jankowska, E. A. (2015). Psychological aspects of heart failure – beyond depression, anxiety and quality of life. Health Psychology Report. https://doi.org/10.5114/hpr.2015.49938
478. Silva, E. P. D., Maso, A. D. S., Moura, S. G. F., Andrade, T. T. D., Oliveira, V. D. L., Oliveira, R. B., Andrade, T. T. D., Lídio, M. D. S., Jales, W. K. B., & Araújo, L. F. D. (2022). Violência obstétrica: uma análise de conceito. AYA Editora eBooks. https://doi.org/10.47573/aya.5379.2.95.4
479. Silva, F. F. D., Bernardo, T. A. C., Rodrigues, J. R. D. S., & Félix, P. T. (2023). Dissociative identity disorder (DID) in the Brazilian population: a literature review. IJS - International Journal of Sciences. https://doi.org/10.29327/229003.5.3-2
480. Silvestrini, N. (2014). [Implication of cognitive control capacity in pain experience].. PubMed.
481. Simeon, D., & Abugel, J. (2006). Diagnosing Depersonalization Disorder. https://doi.org/10.1093/oso/9780195170221.003.0005
482. Simeon, D., & Abugel, J. (2006). Expressions of the Inexpressible. https://doi.org/10.1093/oso/9780195170221.003.0003
483. Simeon, D., & Abugel, J. (2006). Unraveling the Enigma: Clinical Research on Depersonalization Disorder. https://doi.org/10.1093/oso/9780195170221.003.0006
484. Simon, O. (2007). Dépression après accident vasculaire cérébral. Sang thrombose vaisseaux. https://doi.org/10.1684/stv.2007.0137
485. Singh, A., & Dubey, A. P. (2015). Role of Social Support as a Mediator in Negative Stressful Life Event and Somatic Complaints of Managerial Personnel. Indian Journal of Positive Psychology.
486. Singh, P. K. (2015). Psychogenic Headache in School Going Children. Indian Journal of Health and Wellbeing.
487. Singh, S. (2015). Mental health in infancy. International Journal of Clinical & Medical Imaging. https://doi.org/10.4172/2376-0249.1000393
488. Sinha, S., Moss, A. J., & Calkins, H. (2007). The etiology of sudden death. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544828.014
489. Smith, G. D. (2006). More questions than answers?. Gastrointestinal Nursing. https://doi.org/10.12968/gasn.2006.4.4.21138
490. Smith, P. J., & Blumenthal, J. A. (2015). Exercise and Physical Activity in the Prevention and Treatment of Depression. Routledge eBooks. https://doi.org/10.4324/9780203132678.ch8
491. Smith, S. S. (2019). Insomnia and Clinical Sleep Disturbance in Later Life. Oxford Research Encyclopedia of Psychology. https://doi.org/10.1093/acrefore/9780190236557.013.419
492. Soares, H. L. R., Costa, R. A., & Mesquita, E. T. (2006). Depressão e as doenças cardiovasculares. Revista do Departamento de Psicologia UFF. https://doi.org/10.1590/s0104-80232006000200016
493. Spasova, R. G. (2019). ETHICAL CONSIDERATIONS IN THE INTEGRATED CARE FOR PATIENTS WITH CHRONIC PAIN. Knowledge International Journal.
494. Spector, P. E. (2002). Employee Control and Occupational Stress. Current Directions in Psychological Science. https://doi.org/10.1111/1467-8721.00185
495. Spetruk, P., & Opala, G. (2005). Wieloaspektowy charakter depresji występującej po udarze mózgu. Udar Mózgu.
496. Spiegel, E. P., & Vanderploeg, R. D. (2010). Postconcussion Syndrome. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0696
497. Stacher, G. (1993). Psyche, personality and gut functions. Neurogastroenterology & Motility. https://doi.org/10.1111/j.1365-2982.1993.tb00110.x
498. Starkstein, S., & Robinson, R. G. (1989). Affective Disorders and Cerebral Vascular Disease. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.154.2.170
499. Stefano, G. B., Esch, T., Fricchione, G. L., & Benson, H. (2002). Stress in cardiovascular diseases.. PubMed.
500. Steffens, D. C., Blazer, D. G., & Beyer, J. L. (2013). Mood Disorders. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781615370016.mt05
501. Steil, R., Gutermann, J., Harrison, O., Starck, A., Schwartzkopff, L., Schouler‐Ocak, M., & Stangier, U. (2019). Prevalence of prolonged grief disorder in a sample of female refugees. BMC Psychiatry. https://doi.org/10.1186/s12888-019-2136-1
502. Steinert, C., Heim, N., & Leichsenring, F. (2021). Procrastination, Perfectionism, and Other Work-Related Mental Problems: Prevalence, Types, Assessment, and Treatment—A Scoping Review. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2021.736776
503. Steptoe, A. (2017). Depression and negative emotions. Routledge eBooks. https://doi.org/10.4324/9781315673097-6
504. Stewart, S. M. (2013). Depression. The Encyclopedia of Cross‐Cultural Psychology. https://doi.org/10.1002/9781118339893.wbeccp158
505. Stiefel, F., Bourquin, C., & Saraga, M. (2019). [A relationship under the influence : collusive phenomena in clinics].. PubMed.
506. Stojaković, M., Vukadinović, S., & Stojanović, Z. (2017). STRES KAO FAKTOR RIZIKA U NASTANKU DEPRESIJE NAKON MOŽDANOG UDARA. Psymedica. https://doi.org/10.7251/psy1201016v
507. Stone, J., & Sharpe, M. (2020). Functional neurological symptom disorder (conversion disorder). Oxford University Press eBooks. https://doi.org/10.1093/med/9780198713005.003.0133
508. Stone, J., Carson, A., & Sharpe, M. (2005). Functional symptoms in neurology: management. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2004.061663
509. Stone, J., Pal, S., Blackburn, D., Reuber, M., Thekkumpurath, P., & Carson, A. (2015). Functional (Psychogenic) Cognitive Disorders: A Perspective from the Neurology Clinic. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-150430
510. Suh, S.-H. (2005). Eastside Psychiatric Services.
511. Sullivan, D. P. (2018). The Psychological Evaluation. CRC Press eBooks. https://doi.org/10.1201/b22240-12
512. SUMINAR, T. E. L., & Diniari, N. K. S. (2023). GANGGUAN CEMAS PADA LANSIA : SEBUAH LAPORAN KASUS. HEALTHY Jurnal Inovasi Riset Ilmu Kesehatan. https://doi.org/10.51878/healthy.v2i2.2574
513. Summerfield, D. (2006). Depression: epidemic or pseudo-epidemic?. Journal of the Royal Society of Medicine. https://doi.org/10.1258/jrsm.99.3.161
514. Sushmitha, S., Shivakumara, J., & Mathias, T. (2023). Stress, a Great Impact on Mental Health. Asian Journal of Nursing Education and Research. https://doi.org/10.52711/2349-2996.2023.00050
515. Swann, A. C. (2007). Psychiatric Emergencies in Bipolar and Related Disorders.
516. Swann, A. C. (2009). Pharmacologic Mood Destabilization: <i>Case Vignettes</i>. CNS Spectrums. https://doi.org/10.1017/s1092852900003898
517. Szyguła‐Jurkiewicz, B., Duszańska, A., & Poloński, L. (2008). Is depression a problem in patients with chronic heart failure?. Polskie Archiwum Medycyny Wewnętrznej. https://doi.org/10.20452/pamw.304
518. Sönmez, D., Okumuş, B., & Hocaoğlu, Ç. (2021). The Occurrence of Funeral Mania After Bereavement: A Case Report. Medeniyet Medical Journal. https://doi.org/10.5222/mmj.2021.58998
519. Tacn, A. (2012). PTSD in the Context of Malignant Disease. InTech eBooks. https://doi.org/10.5772/27424
520. Tamam, L., & Zengin, M. (2011). Aralikli Patlayici Bozukluk Intermittent Explosive Disorder.
521. Tan, J. C. H. (2013). Mental Health. The Encyclopedia of Cross‐Cultural Psychology. https://doi.org/10.1002/9781118339893.wbeccp357
522. Tang‐Wai, D. F., Josephs, K. A., & Petersen, R. C. (2005). Alzheimer's disease: overview. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544873.029
523. Tatulian, S. E., Vasiliev, S. V., Yavorskaya, V. V., & Zheltyakova, Z. A. (2005). The Influence of Somatoneurological Decompensations in the Course of Old-Age Depressive Disorders. International Journal of Mental Health. https://doi.org/10.2753/imh0020-7411340410
524. Teja, N., Gummadi, O. D., Devi, B. V., & Pavani, N. (2020). Evaluation of Depressant Activity on Mansoa alliacea on Rats. Acta Scientific Pharmaceutical Sciences. https://doi.org/10.31080/asps.2020.04.0617
525. Tennant, C., Bebbington, P., & Hurry, J. (1981). The role of life events in depressive illness: is there a substantial causal relation?. Psychological Medicine. https://doi.org/10.1017/s0033291700052193
526. Terman, M., & Terman, J. S. (2013). Chronotherapeutics. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781139175869.026
527. Terçariolli, B. I., Rosa, J. M., Vieira, G. P., Cardoso, R., & Lage, P. S. (2024). RESUMO Introdução: Os transtornos mentais são definidos como sendo síndromes caracterizadas por uma perturbação clinicamente expressiva na cognição, na regulação emocional ou no comportamento de um indivíduo, que refletem uma disfunção nos processos psicológicos, biológicos ou de desenvolvimento subjacentes ao funcionamento mental. Estes estão frequentemente associados ao sofrimento ou às incapacidades. Sabe-se que uma das características marcantes de determinados transtornos está relacionada à…. Revista fisio&terapia.. https://doi.org/10.69849/revistaft/fa1020240911111905
528. Thakur, A., Choudhary, D., Kumar, B., & Chaudhary, A. (2021). A Review on Post-traumatic Stress Disorder (PTSD): Symptoms, Therapies and Recent Case Studies. Current Molecular Pharmacology. https://doi.org/10.2174/1874467214666210525160944
529. Thom, R. P., Silbersweig, D., & Boland, R. (2019). Major Depressive Disorder in Medical Illness: A Review of Assessment, Prevalence, and Treatment Options. Psychosomatic Medicine. https://doi.org/10.1097/psy.0000000000000678
530. Tickner, N., Apps, J., Keady, S., & Sutcliffe, A. (2012). An overview of drug therapies used in the treatment of dystonia and spasticity in children. Archives of Disease in Childhood Education & Practice. https://doi.org/10.1136/archdischild-2011-301170
531. Tollefson, G. D., Souêtre, E., Thomander, L., & Potvin, J. H. (1993). Comorbid anxious signs and symptoms in major depression. International Clinical Psychopharmacology. https://doi.org/10.1097/00004850-199300840-00013
532. Tomycz, N., & Campbell, T. P. (2023). Musculoskeletal and Neurogenic Pain. Cambridge University Press eBooks. https://doi.org/10.1017/9781316338513.008
533. Tonković, D., Adam, V. N., Kovačević, M., Bogović, T. Z., Drvar, Z., & Baronica, R. (2012). [Perioperative disorders of mental functions].. PubMed.
534. Toudou‐Daouda, M., Assadeck, H., Obenda, N. S., & Souirti, Z. (2017). Céphalées épileptiques isolées : revue de la littérature. Isolated epileptic headache : review. African & Middle East Epilepsy Journal.
535. Treder, N., & Jodzio, K. (2014). Prevalence and clinical specificity of fatigue symptoms in chronic fatigue syndrome, multiple sclerosis, and myasthenia gravis. Health Psychology Report. https://doi.org/10.5114/hpr.2014.43914
536. Trill, M. D. (2012). Psychological aspects of depression in cancer patients: an update. Annals of Oncology. https://doi.org/10.1093/annonc/mds350
537. Trojanowska, M. (2017). Społeczny i medyczny wymiar seksualności osób z niepełnosprawnością na przykładzie osób chorych na stwardnienie rozsiane. Acta Universitatis Lodziensis Folia Sociologica. https://doi.org/10.18778/0208-600x.60.08
538. Tso, I. F., Chun, J., & Deldin, P. J. (2010). Schizoaffective Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0818
539. Turabián, J. L. (2023). Doctor patient communication Content or process. Journal of Clinical and Medical Images Case Reports. https://doi.org/10.55920/2771-019x/1584
540. Tyrer, P., Crawford, M., & Reed, G. M. (2015). Personality disorder 1 Classifi cation, assessment, prevalence, and eff ect of personality disorder.
541. Tütüncü, R. (2011). Chronic pain, psychological factors and depression. Dicle Medical Journal / Dicle Tip Dergisi. https://doi.org/10.5798/diclemedj.0921.2011.2.0028
542. Tütüncü, R. (2011). •Chronic pain, psychological factors and depression. Dicle Medical Journal / Dicle Tip Dergisi. https://doi.org/10.5798/diclemedj.0921.2011.02.0028
543. Umar, S. H., & Hermida, H. (2019). PENERAPAN KECERDASAN EMOSIONAL DALAM MENGATASI STRES SISWA DI SEKOLAH. Foramadiahi Jurnal Kajian Pendidikan dan Keislaman. https://doi.org/10.46339/foramadiahi.v10i2.119
544. Uppal, T., Amarasekara, C., & Kaushik, V. (2011). Chronic pelvic pain. Australasian Journal of Ultrasound in Medicine. https://doi.org/10.1002/j.2205-0140.2011.tb00182.x
545. Ventura, T. (2011). Depressão e comorbilidade: Um caso clínico. Revista Portuguesa de Clínica Geral. https://doi.org/10.32385/rpmgf.v27i1.10816
546. Vicente, M. O., Gutiérrez, L. E. J. F., & Oves, M. I. R. (2011). ALCOHOLISMO CONSECUTIVO AL TRASTORNO DE PÁNICO. DOAJ (DOAJ: Directory of Open Access Journals).
547. Villamar, S., & Lorena, J. (2019). Factores psicosociales y depresión geriátrica en un paciente.
548. Villarroya, B. G., Voicu, A., Catalán, P. T., & Lopez, P. (2021). La soledad en el anciano, presentación de un caso clínico. Revista Sanitaria de Investigación.
549. Vinik, A., & Casellini (2013). Guidelines in the management of diabetic nerve pain clinical utility of pregabalin. Diabetes Metabolic Syndrome and Obesity. https://doi.org/10.2147/dmso.s24825
550. Vk, A., & Vd, K. (2013). Clinical profiles and symptoms of childhood depression.. PubMed.
551. Vuppalapati, C., Kedari, S., Ilapakurti, A., Kedari, S., & Shankar, J. (2019). Emotional Health: A Data Driven Approach to Understand our Emotions and Improve our Health. https://doi.org/10.1109/cse/euc.2019.00071
552. Víu, C. M. D., & Blasco, J. M. (2011). Salud laboral y salud mental: estado de la cuestión. Medicina y Seguridad del Trabajo. https://doi.org/10.4321/s0465-546x2011000500001
553. Wadhwa, R., & Khandare, M. (2014). Stress Management through Yoga. Global Journal of Human-Social Science.
554. Wahyuningsih, S., Nurun, N., Ainul, A., Rendra, R., & Dwiki, D. (2020). Relaksasi Nafas Dalam Terhadap Tingkat Kecemasan Pada Lansia Yang Menderita Hipertensi Di RT 03 RW 09 Kelurahan Slipi Palmerah Jakarta Barat. JURNAL KREATIVITAS PENGABDIAN KEPADA MASYARAKAT (PKM). https://doi.org/10.33024/jkpm.v3i2.3194
555. Walder, D. J., Statucka, M., Daly, M., & Yaffe, B. (2014). Psychotic Disorders. Psychology. https://doi.org/10.1093/obo/9780199828340-0151
556. Walker, M. C., & Sander, J. W. (2011). Epilepsy and Sleep Disorders. CRC Press eBooks. https://doi.org/10.1201/b13388-13
557. Wang, S. (2013). Research development of posttraumatic growth and metal health. Chinese Journal of Injury Repair and Wound Healing.
558. Webb, A. M. B., Ford, S. C., & Santiago, P. N. (2018). Adjustment Disorder. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190457136.003.0005
559. Weems, C. F. (2019). The importance of the post-disaster context in fostering human resilience. The Lancet Planetary Health. https://doi.org/10.1016/s2542-5196(19)30014-2
560. Wenzel, T., & Zhu, L. (2013). Posttraumatic Stress in Athletes. https://doi.org/10.1002/9781118404904.ch10
561. Westgaard, R. H. (1996). Non-voluntary muscle activity and myofascial pain syndromes. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511570193.018
562. Whitecross, S. (2020). Traumatic Brain Injury in Children: The Psychological Effects of Mild Traumatic Brain Injury. Journal of Binocular Vision and Ocular Motility. https://doi.org/10.1080/2576117x.2020.1815502
563. Wiegant, V. M. (1991). [Stress].. PubMed.
564. Williams, A. C. D. C., & Cella, M. (2012). Medically unexplained symptoms and pain. Current Opinion in Supportive and Palliative Care. https://doi.org/10.1097/spc.0b013e328352124f
565. Williams, T. A. (1914). THE SYNDROME OF ADRENAL INSUFFICIENCY. Journal of the American Medical Association. https://doi.org/10.1001/jama.1914.02570250033009
566. Wimalawansa, S. J. (2013). Causes and Risk Factors for Post-Traumatic Stress Disorder: The Importance of Right Diagnosis and Treatment. Asian Journal of Medical Sciences. https://doi.org/10.3126/ajms.v5i2.8537
567. Wimalawansa, S. J. (2013). Causes and Risk Factors for Post-Traumatic Stress Disorder: The Importance of Right Diagnosis and Treatment. Asian Journal of Medical Sciences. https://doi.org/10.71152/ajms.v5i2.3318
568. Winkelmann, C., & Schreiber, T. (2019). Using ’White Flags’ to categorize socio-cultural aspects in chronic pain. European Journal of Public Health. https://doi.org/10.1093/eurpub/ckz186.196
569. Winokur, G. (1970). Genetic Findings and Methodological Considerations in Manic Depressive Disease. The British Journal of Psychiatry. https://doi.org/10.1192/s0007125000193237
570. Winter, A., & Buhlmann, U. (2013). Spieglein, Spieglein an der Wand … Klinische Charakteristika der körperdysmorphen Störung. Zeitschrift für Psychiatrie Psychologie und Psychotherapie. https://doi.org/10.1024/1661-4747/a000155
571. Worthen, R. J., & Beurel, E. (2022). Inflammatory and neurodegenerative pathophysiology implicated in postpartum depression. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2022.105646
572. Wróbel, M. R., & Mosiołek, A. (2018). Dysfunkcje seksualne w przebiegu zaburzeń depresyjnych.
573. Yancon, L. (2015). Pulse condition of insomnia. Journal of Changchun University of Chinese Medicine.
574. Yang, B.-K., Yi, S.-R., Ahn, Y.-J., Im, S. H., & Park, S. H. (2016). Ischial Tuberosity Avulsion Stress Fracture after Short Period of Repetitive Training. Hip & Pelvis. https://doi.org/10.5371/hp.2016.28.3.187
575. Yennurajalingam, S., & Bruera, É. (2015). Fatigue and asthenia. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199656097.003.0081
576. Young, W. B., Packard, R. C., & Katsarava, Z. (2007). Headaches Associated with Head Trauma. https://doi.org/10.1093/oso/9780195326567.003.0016
577. Yutzy, S. H. (2015). Somatic Symptom and Related Disorders: Somatic Symptom Disorder, Illness Anxiety Disorder, and Conversion Disorder. Psychiatry. https://doi.org/10.1002/9781118753378.ch62
578. Zhu, Y., Han, G., & Li, S. (2019). Chronic Fatigue Stress and Sudden Death. IntechOpen eBooks. https://doi.org/10.5772/intechopen.88649
579. Çelik, F. H., & Hocaoğlu, Ç. (2016). Major Depressive Disorder' Definition, Etiology and Epidemiology: A Review -. Journal of Contemporary Medicine.
580. Ćelap, S. (2019). Depresivnost kod djece i mladih.
581. Đurić, V., & McCarson, K. E. (2006). Hippocampal Mechanisms Linking Chronic Pain and Depression. Journal of Neuropathic Pain & Symptom Palliation. https://doi.org/10.3109/j426v02n04_03